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Summary
Promoter-proximal  pausing  is  a  wide-spread  phenomenon  in  metazoans.  RNA
polymerase II is stably paused after transcribing 20-60 nucleotides of a gene and awaits
controlled release.  First  considered a rare phenomenon, this mechanism was recently
recognized as a key regulatory step in controlling transcription for the majority of genes.
The four-subunit negative elongation factor (NELF) is essential for establishing promoter-
proximal  pausing.  Despite years  of  study,  structural  information  is  known only  for  the
NELF-E  RRM  domain  and  is  lacking  for  the  rest  of  the  complex.  A high-resolution
structure of NELF would greatly contribute to understanding the role of NELF in promoter-
proximal pausing and provide an important basis for further research. 
In  this work,  a highly conserved NELF subcomplex consisting of  NELF-A (6-188) and
NELF-C (183-590) was identified, crystallized and its structure solved to 2.8 Å resolution.
Both  subunits  interact  extensively. NELF-C adopts a horse-shoe shaped conformation
including a CTD-interacting domain (CID)-like domain at its C-terminus. The NELF-A C-
terminal region (111-182) stretches across NELF-C. The NELF-A N-terminal region (6-110)
forms a highly conserved domain with structural similarity to the  HIV integrase-binding
domain in human PC4 and SFRS1-interacting protein.
Analysis  of  the  NELF-AC surface  revealed  that  the  exterior  of  the  complex  contains
several  large,  positively  charged  patches.  Fluorescence  anisotropy  experiments
demonstrated that NELF-AC specifically interacts with single stranded nucleic acids in a
strongly  sequence dependent  manner.  Mutation of  the positive patches confirmed the
importance of surface residues in nucleic acid binding. Three previously identified in vivo
NELF-AC phosphorylation  sites  are  located  close  to  the  surface  regions  involved  in
nucleic acid binding and phosphomimetic mutations of these sites effectively decrease
affinity  of  NELF-AC for  nucleic  acids.  NELF activity  is  tightly  regulated by the kinase
positive  transcription  elongation  factor  (P-TEFb).  Treatment  of  NELF-AC with  P-TEFb
revealed two novel phosphorylation sites that have a strong, inhibitory effect on nucleic
acid binding by NELF-AC. Finally, crosslinking of a four-subunit NELF complex coupled
with mass-spectrometry elucidated the architecture of the complete NELF complex and
confirmed  that  the  nucleic  acid  binding  surfaces  identified  in  the  NELF-AC  crystal
structure are accessible in solution.
These results suggest a possible model for NELF action at the molecular level. NELF-AC
contributes to pausing by binding to nascent RNA in a sequence dependent manner to
additionally  stabilize  the  pausing  complex  and  further  enhance  promoter-proximal
pausing.
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 I Introduction
 1 Transcription of genes in eukaryotes
 1.1 DNA-dependent RNA polymerases
To adapt to a changing environment and maintain basic metabolic processes, a cell needs
to transcribe the information contained in its DNA into various types of RNA continuously
and dynamically. In most organisms, production of RNA is performed by DNA-dependent
RNA polymerases,  with the exception of  some viruses  that  use RNA-dependent  RNA
polymerases to synthesize RNA (te Velthuis, 2014). DNA-dependent RNA polymerases
consist of one or more subunits and are tightly regulated by transcription factors (Cramer,
2002a; Thomas and Chiang, 2006). Different than in viruses and organelles, complex RNA
polymerases  composed  of  several  different  subunits  evolved  in  all  living  organisms
(Cramer, 2002b). Bacteria and Archaea contain only one multi-subunit RNA polymerase
consisting of five and twelve subunits, respectively (Werner and Grohmann, 2011).
In eukaryotes, five multi-subunit  RNA polymerases (Pol) I–V produce different kinds of
RNA (Haag and Pikaard, 2011; Werner, 2007). Whereas Pol I transcribes only one gene,
the 45S ribosomal RNA (rRNA),  Pol  II  synthesizes all  pre-messenger  RNAs (mRNA),
micro RNAs (miRNA) and most small nuclear RNAs (snRNA) and Pol III produces many
untranslated RNAs like translator RNAs (tRNA) and 5S rRNA (Roeder and Rutter, 1970;
Thomas and Chiang, 2006). Pol IV and V exist  only in plants and are involved in the
biogenesis of siRNA and heterochromatin formation (Haag and Pikaard, 2011).
Pol I, II and III are composed of 14, 12 and 17 subunits, respectively. Ten subunits are
structurally homologous among all three Pols and represent the conserved core of the
enzyme (Table 1) (Vannini and Cramer, 2012). Pol I and III contain additional subunits not
present in the Pol II core enzyme. Homologs of these unique Pol I and Pol III subunits are
transiently associated with Pol II during transcription and are known as initiation specific
transcription factors (TFs) (Table 1) (Vannini and Cramer, 2012). Permanent association of
homologous Pol II transcription factor homologues to Pol I and III likely results from the
greater transcriptional specialization of Pol I and Pol III. The mechanism of transcription
initiation between Pol  I-III  is  similar  in that  all  are recruited by auxiliary factors to the
correct transcription start site (TSS) (Table 1)  (Vannini and Cramer, 2012). A plethora of
additional proteins regulate Pol II activity in a cell and gene specific manner (Sikorski and
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Buratowski, 2009; Thomas and Chiang, 2006).
Table 1: RNA polymerase subunits and initiation factor homologues in yeast.
Adapted from (Vannini and Cramer, 2012).
Pol I Pol II Pol III
Polymerase Core
A190 Rpb1 C160
A135 Rpb2 C128
AC40 Rpb3 AC40
Rpb5 Rpb5 Rpb5
Rpb6 Rpb6 Rpb6
Rpb8 Rpb8 Rpb8
A12.2 N-ribbon Rpb9 C11 N-ribbon
Rbp10 Rpb10 Rpb10
AC19 Rpb11 AC19
Rbp12 Rpb12 Rpb12
Polymerase Stalk
A14 Rpb4 C17
A43 Rpb7 C25
Pol II transcription factors and homologues in Pol I and Pol III
A49 N-terminal domain Tfg1 (TFIIFα) C37
A34.5 Tfg2 (TFIIFβ) C53
Tfa1 (TFIIEα) C82
A49 C-terminal domain Tfa2 (TFIIEβ) C34
C31
 1.2 Eukaryotic RNA polymerase II
Eukaryotic Pol II is a highly conserved protein complex with a mass greater than 500 kDa
and consists of 12 subunits in S.cerevisiae (Figure 1) (Armache et al., 2005; Cramer et al.,
2001). The yeast Pol II crystal structure (Cramer et al., 2001), initiation complex (Cheung
et al., 2011; Liu et al., 2011; Sainsbury et al., 2015; Sainsbury et al., 2013) and elongation
complex  (Figure  1)  (Gnatt  et  al.,  2001;  Kettenberger  et  al.,  2004) as  well  as  other
functional complexes (Cheung and Cramer, 2011; Kostrewa et al., 2009; Plaschka et al.,
2015;  Sydow et  al.,  2009) have been characterized.  Mammalian Pol  II  has  not  been
crystallized yet, but medium-resultion structures of human Pol II complexes obtained by
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cryo-electron microscopy studies are available  (Bernecky et al.,  2011; He et al., 2013;
Kassube et al., 2013).
Ten subunits invariantly constitute the core enzyme. Subunits Rbp 4 and Rpb 7 form the
peripheral ‘stalk’ subcomplex (Figure 1) that is required for transcription initiation and can
dissociate from the core enzyme in yeast (Edwards et al., 1991).
Pol II  comprises a ‘central cleft’ that encompasses the DNA template and harbors the
highly conserved ‘bridge helix’ – the active site – at its base (Figure 1)  (Cramer et al.,
2001; Weinzierl, 2011). The cleft is defined by the two largest subunits Rbp1 and Rpb2
and confined by three distinctive domains called ‘clamp’, ‘lobe’ and ‘protrusion’.  Newly
synthesized RNA exits the cleft through a RNA exit-tunnel located between the active site
and  the  clamp  and  resurfaces  near  the  clamp  (Figure  1)  (Andrecka  et  al.,  2008;
Kettenberger et al., 2004).
The clamp (Figure 1) is a highly conserved structural feature of Pol II. The mobile clamp
adopts  an  ‘open’ conformation  in  the  ten-subunit  complex  (Cramer  et  al.,  2001) and
switches to a ‘closed’ conformation after Pol II binds DNA encircling the template (Gnatt et
al., 2001). The closed conformation is stabilized by Rpb4/7  (Armache et al., 2003). The
3
Adapted from (Martinez-Rucobo et al., 2011).  Both perspectives are related by a 90° turn around
the vertical  axis.  Parts of  Pol  II  domains interacting with Spt4/5 (clamp coiled coil)  or  in close
proximity (protrusion and lobe) are colored. Rpb4/7 and the bridge helix are labeled for orientation.
The arrow indicates the direction of movement of  transcribing Pol II.  Pol II, Spt4 and Spt5 are
coloured in grey, yellow and green, respectively. DNA and RNA are blue and red, respectively.
Figure 1: Model of eukaryotic Pol II-DSIF elongation complex.
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inner  side  of  the  clamp  interacts  with  DNA  (Gnatt  et  al.,  2001),  the  outer  side  with
interchanging accessory factors during the transcription cycle (Grohmann et al., 2011) like
TFIIE (Chen et al., 2007), Spt4/5 (Klein et al., 2011; Martinez-Rucobo et al., 2011) or the
human hepatitis virus delta antigen (HDAg) (Yamaguchi et al., 2007).
The C-terminal repeat domain (CTD) of Rbp1 is unique to Pol II. The CTD serves as a
binding platform for RNA modifying enzymes positioned close to the RNA exit tunnel and
coordinates RNA synthesis  and co-transcriptional  processing  (Martinez-Rucobo  et  al.,
2015; Munoz et al., 2010; Perales and Bentley, 2009; Proudfoot et al., 2002). The CTD is
also important to recruit transcription regulation factors (Napolitano et al., 2014; Proudfoot
et  al.,  2002).  The  CTD  consists  of  a  repetitive  heptapeptide  sequence  (consensus
sequence  Y1S2P3T4S5P6S7)  that  is  variably  phosphorylated  during  the  course  of  the
transcription  cycle  (Heidemann  et  al.,  2013).  The  dynamic  phosphorylation  pattern  is
thought to be the molecular basis for the recruitment of different factors at various stages
of the transcription process (Buratowski, 2009).
 2 The transcription cycle of RNA polymerase II
Transcription of eukaryotic genes by Pol II is divided into three highly regulated steps:
(I)  initiation,  (II)  elongation  and  (III)  termination  (Figure  2)  (Hahn  and  Young,  2011;
Nechaev and Adelman, 2011). The elongation step can be subdivided in early elongation
IIa and productive elongation IIb, respectively.
4
Figure 2: The transcription cycle of eukaryotic RNA polymerase II.
Adapted from: (Nechaev and Adelman, 2011).
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Prior  to  initiation  the  pre-initiation  complex  (PIC)  consisting  of  general  transcription
initiation factors (Table 2) and Pol II assembles at the promoter DNA and creates a short
region of single stranded (ss) DNA – the transcription bubble – where transcription can
take place (He et al., 2013; Muhlbacher et al., 2014; Sainsbury et al., 2015). A minimum of
five general transcription factors (GTFs) are necessary to recruit Pol II to the promoter and
start transcription (Table 2) (Sikorski, Buratowski 2009, Thomas and Chiang 2006). Aided
by the non-essential factor TFIIA (Thomas and Chiang, 2006) the TATA-binding protein
(TBP) subunit of the multi-protein complex TFIID recognizes the AT-rich promoter TATA-
box sequence and upon binding bends the DNA by 90° (Kim et al., 1993; Tsai and Sigler,
2000). TBP is also important for activating TATA-less genes and initiation of Pol I and Pol
III  (Sadowski  et  al.,  1993;  White and Jackson,  1992).  TFIIB stabilizes  the TFIID-DNA
complex and recruits a Pol II – TFIIF complex to the promoter site (Bushnell et al., 2004;
Kostrewa  et  al.,  2009;  Orphanides  et  al.,  1996;  Sainsbury  et  al.,  2013).  Consecutive
binding of TFIIE and TFIIH completes PIC assembly (Forget et al., 2004; Watanabe et al.,
2003).
Transcription  initiation  starts  with  unwinding  DNA and  promoter  melting  stimulated by
TFIIE and TFIIH resulting in  a transcription bubble with a 15 nt  single stranded DNA
(Holstege et al., 1996; Kim et al., 2000). When single stranded DNA is available in the
active site of the open promoter complex, incorporation of the first nucleotides can begin. 
Once  the  newly  synthesized  RNA has  reached  a  length  of  10  nt  transcribing  Pol  II
escapes from the promoter region. The initially unstable transcription process gradually
stabilizes  and after  25  nt  the  early  elongation  phase  begins  (Jonkers  and Lis,  2015;
Margeat et al., 2006; Shandilya and Roberts, 2012). Phosphorylation of the Pol II CTD at
serine 5 is a critical step in the transition from initiation to elongation (Buratowski, 2009).
After promoter escape of Pol II a part of the PIC – TFIIA, -D, -E and -H – remains bound
to the promoter to enhance recruitment of another Pol II molecule and facilitate reinitiation
of transcription (Yudkovsky et al., 2000).
For many metazoan genes, Pol II pauses after transcribing 20-60 nt and remains stably
bound to DNA and RNA  (Kwak and Lis,  2013).  Additional  factors are required before
elongation  is  resumed  (Chiba  et  al.,  2010).  This  process  is  called  promoter-proximal
pausing and will be discussed in more detail later. Once promoter-proximally paused Pol II
is released productive elongation ensues.
During  elongation,  nucleosomes  are  a  major  obstacle  to  transcribing  Pol  II  that  is
overcome by extensive  histone modification and displacement mediated by numerous
chromatin-modifying enzymes (Kulaeva et al., 2013; Saunders et al., 2006). Chromatin of
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activated genes exhibits a distinct pattern of post-translational histone modifications (Li et
al.,  2007;  Shilatifard,  2006).  Methylations H3K27me3 and H3K9me3 as well  as  other
modifications  that  lead  to  silencing  are  removed  during  activation  and  replaced  by
acetylation  of  histones  H3  and  H4,  methylations  H3K36me3  and  H3K79me3,
phosphorylation H3S10P and other modifications. Furthermore mRNA splicing at intron-
exon junctions constitutes a transcription rate-decreasing process (Jonkers and Lis, 2015;
Kwak et al., 2013).
Termination is predominantly mediated through the poly(A)-dependent pathway (Kuehner
et al., 2011). A highly conserved poly(A) signal sequence positioned upstream (AAUAAA)
and  a  G/U-rich  sequence  positioned  immediately  downstream  of  the  genes  3'  end
decelerate  and finally  pause  Pol  II.  Joint  action  of  several  factors  including  cleavage
stimulation  factor  (CstF),  cleavage  and  polyadenylation  specificity  factor  (CPSF)  and
polyadenylate-polymerase (poly(A)-Pol) lead to cleavage of the nascent transcript and 3'
polyadenylation of the transcribed mRNA by addition of 100-200 adenosines (Kuehner et
al., 2011; Nag et al., 2007).
Table 2: General transcription factors in human and their functions.
Adapted from (Thomas and Chiang, 2006).
Factor Subunits Function
TFIIA a 3 Stabilization of TATA-TBP complex
TFIIB 1 TSS selection, recruits pol II/TFIID,
stabilization of TATA-TBP complex
TFIID 15 Core promoter-binding, coactivator, protein kinase,histone acetyltransferase, TBP is a subunit
TFIIE 2 Recruits TFIIH,
formation of an initiation-compentent pol II,
promoter clearance 
TFIIF 2 Pol II binding to promoter,
recruits TFIIE and -H,
TSS selection and promoter escape
TFIIH 10 Helicase activity, phosphorylate CTD
a non-essential for transcription initiation
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 3 Promoter-proximal pausing
 3.1 Prevalence and relevance
Gene  expression  of  many  metazoan  genes  is  regulated  during  early  elongation  by
promoter-proximal pausing (ppp) (Kwak and Lis, 2013). Elongating Pol II stably pauses at
a position 20-60 bp downstream of the TSS and is released only upon phosphorylation of
Pol II and other factors by the kinase complex positive transcription elongation factor b (P-
TEFb) (Yamaguchi, Shibata, Handa, 2012, Adelman, Lis 2012). It was long thought that
gene expression was primarily regulated during transcription initiation. Recently promoter-
proximal pausing was recognized as a key event in the regulation of many genes during
transcription elongation  (Jonkers and Lis, 2015; Li and Gilmour, 2011; Yamaguchi et al.,
2013).
Promoter-proximal  pausing  was first  discovered by  in  vivo  analysis  of the  Drosophila
melanogaster  heat  shock  genes hsp70  and  hsp26  that  exhibited  Pol  II  accumulation
downstream of the TSS prior to induction  (Giardina et al., 1992; Gilmour and Lis, 1986;
Rasmussen  and  Lis,  1993;  Rougvie  and  Lis,  1988).  The  accumulated  Pol  II  is
transcriptionally engaged as demonstrated by permanganate footprinting and is able to
resume transcription (Core et al., 2008; Rougvie and Lis, 1988). The cleavage factor TFIIS
is prevented from cleaving the RNA transcript (Cheung and Cramer, 2011; Palangat et al.,
2005). Therefore the Pol II is in fact stably paused instead and not terminated. Promoter-
proximally paused Pol II  has also been found and studied in more detail at immediate
early genes like  junB (Aida et al.,  2006),  c-myc (Krumm et al.,  1992; Schneider et al.,
1999) and  c-fos (Fivaz  et  al.,  2000;  Plet  et  al.,  1995).  Subsequent  studies  showed
promoter-proximally  paused  Pol  II  to  be  a  common  phenomenon  that  occurs  at  the
majority of genes in the fruit fly Drosophila melanogaster (Guenther et al., 2007; Muse et
al., 2007) and in human (Core et al., 2008; Gilmour, 2009; Guenther et al., 2007). Similar
phenomena have been described in yeast  (Venters and Pugh, 2009) and the nematode
C.elegans (Baugh et al., 2009). However, no distinct proof for promoter-proximal pausing
has  been  found  in  these  organisms  and  promoter-proximal  pausing  is  considered  a
process  specific  to  higher  metazoa.  A comparable  process  of  transient  polymerase
pausing following transcription initiation has been described in bacteria  (Greive and von
Hippel, 2005; Larson et al., 2014; Vvedenskaya et al., 2014).
Promoter-proximal pausing is important for controlling signal-responsive pathways  (Aida
et  al.,  2006;  Krumm  et  al.,  1992;  Plet  et  al.,  1995),  developmental  processes  in
multicellular organisms (Amleh et al., 2009; Keegan et al., 2002; Zeitlinger et al., 2007),
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cell differentiation and reprogramming (Guenther et al., 2007; Williams et al., 2015), and
expression of genes of the human immunodeficiency virus (HIV) (Natarajan et al., 2013;
Zhang et al., 2007). 
 3.2 Involved factors and regulation
Three protein complexes are involved in regulating promoter-proximal pausing. The DRB
sensitivity inducing factor (DSIF)  (Wada et al., 1998; Yamaguchi et al., 1999b), P-TEFb
(Cheng and Price,  2007; Chiba et al.,  2010; Price,  2000) and the negative elongation
factor (NELF) (Pagano et al., 2014; Yamaguchi et al., 1999a). All three factors have also
been detected in vivo simultaneously on the gene loci of hsp70 (Andrulis et al., 2000; Lis
et al., 2000; Wu et al., 2003) or  junB (Aida et al., 2006) containing promoter-proximally
paused Pol II.
 3.2.1 DSIF
DSIF is  a heterodimer  composed of  the human Spt4 (13,2 kDa) and Spt5 (121 kDa)
homologs. Spt5 (NusG in bacteria) is the only transcription factor conserved in all three
domains of life (Werner, 2012). The Nus-G N-terminal (NGN) domain of Spt5 together with
Spt4 constitutes the conserved core of the complex in archaea and eukaryotes (Belogurov
et al., 2007; Guo et al., 2008; Martinez-Rucobo et al., 2011; Wenzel et al., 2010; Zhou et
al., 2009a). The Spt4/5 core binds to the highly conserved Pol II clamp coiled coil motif
(Hirtreiter et al., 2010; Martinez-Rucobo et al., 2011) and to lobe and protrusion on the
opposite side of the cleft closing the Pol II cleft (Figure 1)  (Klein et al., 2011; Martinez-
Rucobo et  al.,  2011).  This contacts prevent DNA release from transcribing Pol II  thus
increasing processivity.  Spt5 further contacts the non-template DNA and stabilizes the
transcription bubble  (Artsimovitch and Landick, 2002). In eukaryotes Spt5 possesses a
814 amino acid long C-terminal tail (273-1087) including five  Kyrpides-Ouzounis-Woese
(KOW) domains and an unstructured C-terminal region (CTR) similar to the Pol II CTD
(Kyrpides et al., 1996; Yamaguchi et al., 1999b). The KOW-domains and the CTR serve
as  binding  platform  for  RNA-processing  factors  and  contribute  to  integrating  RNA-
synthesis and -processing (Mayer et al., 2012; Werner, 2012).
Unphosphorylated  DSIF  suppresses  transcription  whereas  P-TEFb-dependent
phosphorylation of the CTR causes a functional reversion  (Yamada et al.,  2006). CTR
phosphorylation is a critical step in recruitment of elongation factors and progression into
productive elongation and is preserved in all eukaryotes  (Chen et al.,  2009; Liu et al.,
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2009; Qiu et al., 2006; Squazzo et al., 2002; Zhou et al., 2009b).
 3.2.2 NELF
NELF is a multi subunit complex that represses transcription elongation (Wu et al., 2003;
Yamaguchi et al., 2002) and is associated with chromatin (Wu et al., 2005). NELF consists
of four subunits NELF-A, -B, -C or its splicing variant -D, and -E. NELF is present in many
metazoans such as human, zebrafish or fruit fly (Narita et al., 2003) but is also observed
in the single celled organism Dictyostelium discoideum (Chang et al., 2012). NELF has
not been found in yeast, the nematode C. elegans or plants (Narita et al., 2003). NELF is
highly conserved with the exception of a few regions of NELF-A, NELF-C and NELF-E
(Figure  3A).  The  four  NELF  subunits  interact  in  a  linear  manner  and  the  peripheral
subunits NELF-A and NELF-E have been functionally characterized (Narita et al., 2003).
The N-terminus  of  NELF-A binds  to  NELF-C (125-188)  and contains  a  region  that  is
known to associate with Pol II  (189-248)  (Narita et  al.,  2003). The NELF-A C-terminal
region is conserved but is presently uncharacterized. The NELF-A•Pol II binding region
exhibits a weak sequence similarity with  HDAg and possibly  interacts  with Pol  II  in  a
similar way like HDAg by binding the Pol II clamp (Figure 3B)  (Yamaguchi et al., 2001;
Yamaguchi et al., 2007). NELF-E contains a structurally characterized RNA recognition
motif (RRM) that binds RNA in a sequence-dependent manner (Figure 3A) (Pagano et al.,
2014; Rao et al., 2006; Rao et al., 2008). Except for the RRM of NELF-E no structural
information for NELF is available.
NELF is essential for the embryogenesis of higher metazoa (Amleh et al., 2009; Wang et
al.,  2010; Williams et al., 2015) and is required for expression of genes of the human
immunodeficiency virus  (Natarajan et al., 2013; Zhang et al., 2007). NELF has not only
been associated with HIV but was also implicated in the etiology of other viral infections
(Palermo et  al.,  2011;  Toth et  al.,  2012),  genetic diseases like the Wolf-Hirschhausen
syndrome which is characterized by multiple malformations  (Kerzendorfer et al.,  2012;
Wright et al., 1999) or multiple types of chancer (Iida et al., 2012; McChesney et al., 2006;
Sun et al., 2008; Ye et al., 2001).
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 3.2.3 P-TEFb
P-TEFb is a heterodimeric cyclin-dependent kinase composed of cyclin-dependent kinase
9  (CDK9)  and  cyclins  T1,  T2,  or  K (Peterlin  and  Price,  2006).  P-TEFb  was  initially
identified as the primary target of a drug,  5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole
(DRB), which prevents Pol II from producing full-length transcripts (Marshall et al., 1996;
Marshall  and  Price,  1992,  1995;  Zhu  et  al.,  1997).  It  was  later  shown  that  P-TEFb
counteracts  promoter-proximal  pausing  and  enables  productive  elongation  by
phosphorylating the Ser-2 sites of the Pol II CTD  (Cheng and Price, 2007), the Spt4/5
CTR (Yamada et al., 2006) and NELF (Fujinaga et al., 2004). P-TEFb also contributes to
establishing  open  chromatin  by  phosphorylating  histones  (O'Brien  et  al.,  2010).
Conversely,  inhibition  of  P-TEFb  activity  almost  completely  blocks  Pol  II  transcription
elongation  (Henriques et al.,  2013; Jonkers et al.,  2014). Crystal structures of  P-TEFb
alone and in complex with drugs and small peptides are available to provide a mechanistic
basis for its role in transcription (Baumli et al., 2012; Baumli et al., 2008; Schulze-Gahmen
et al., 2014; Schulze-Gahmen et al., 2013; Tahirov et al., 2010). P-TEFb is essential for
10
(A)  Conservation  of  human  NELF  subunits  relative  to  Drosophila  NELF.  NELF-A region  with
sequence similarity to HDAg (Figure 3B) and NELF-E RRM are indicated. Adapted from (Wu et al.,
2005).
(B) Sequence alignment between human (H.s.) NELF-A HDAg-like region and HDAg (P0C6L3).
Identical and conserved residues are colored in green and yellow, respectively. The alignment is
based on (Yamaguchi et al., 2001) and was generated with CluwtalW (Larkin et al., 2007).
Figure 3: Conservation of NELF subunits
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the replication of the human immunodeficieny virus (He et al., 2010; Sobhian et al., 2010).
 3.3 Mechanism and regulation of promoter-proximal pausing
Association of  DSIF and NELF with elongating Pol  II  is  sufficient  to  induce promoter-
proximal pausing  (Missra and Gilmour,  2010; Narita et al.,  2003; Renner et  al.,  2001;
Yamaguchi  et  al.,  1999b). NELF requires a preformed Pol  II-DSIF complex for  stable
binding. The position of Pol II pausing on the gene is a function of the rate of transcription
elongation  and  NELF  binding  efficiency  (Li  et  al.,  2013), which  is  influenced  by
competition with the transcription factor TFIIF (Renner et al., 2001). NELF and DSIF bind
to the elongation complex once nascent RNA is longer than 18 nt and emerges from Pol II
surface (Andrecka et al., 2008; Missra and Gilmour, 2010). Despite a strong association of
the NELF-E RRM with RNA (Pagano et al., 2014; Rao et al., 2008), it was reported that
DSIF, but not NELF contacts nascent RNA (Missra and Gilmour, 2010). Several models
how  promoter-proximal  pausing  is  established  have  been  suggested (Kwak  and  Lis,
2013).
The  kinetic  model  (Figure  4A)  posits  that the  sequence  dependent  rate  of  Pol  II
transcription competes with the efficiency of pausing factor recruitment to thereby affect
extent and location of pausing (Bai et al., 2004; Li et al., 2013; Nechaev et al., 2010). So
far no common cis-element at human pausing sites has been discovered, albeit promoters
with paused Pol II share some characteristics: the respective promoters are CpG rich, lack
a TATA box and contain Pol II CTD Ser-5 but not Ser-2 phosphorylations  (Core et al.,
2008; Kininis et al., 2009; Mavrich et al., 2008). Furthermore, the +1 nucleosome is shifted
downstream at promoters containing paused Pol II and histones carry a unique H3K4 and
H3K27 methylation (Bernstein et al., 2006; Schones et al., 2008).
The nucleosome barrier model (Figure 4B) assumes the first nucleosome after the TSS to
prevent  elongating  Pol  II  from proceeding  further  into  the gene.  Indeed nucleosomes
contribute  to  promoter-proximal  pausing  (Gilchrist  et  al.,  2010;  Gilchrist  et  al.,  2008;
Jimeno-Gonzalez et al., 2015) but are not necessary to pause Pol II. For example the
highly paused Drosophila melanogaster hsp70 gene contains a 5' nucleosome free region
(Fuda et al., 2009; Gilchrist et al., 2010; Yamaguchi et al., 1999a).
The  interaction  model  (Figure  4C)  relies  on  sequence  specific  interaction  between
pausing factors and DNA/RNA as observed in bacteria  (Wang et al., 1997). Indeed, the
NELF-E RRM binds to RNA in a sequence dependent manner (Pagano et al., 2014) and
thereby may contribute to promoter-proximal pausing (Yamaguchi et al., 2002).
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In  some  cases  estrogen-dependent  recruitment  of  NELF  or  sequence-dependent
recruitment of DSIF to specific sites is pivotal for setting up promoter-proximal pausing
(Aiyar et al., 2004; Amir-Zilberstein et al., 2007).
Phosphorylation of NELF, DSIF and Pol II CTD by P-TEFb is critical for pause release
(Figure 5) and promoter-proximal pausing is mainly regulated by spatiotemporal regulation
of P-TEFb catalytic activity (Chiba et al., 2010; Peterlin and Price, 2006; Yamaguchi et al.,
2013).
P-TEFb is recruited to specific genomic target sites by sequence specific factors such as
the heat shock factor (hsf) (Lis et al., 2000) or the bromodomain-containing protein Brd4
(Hargreaves  et  al.,  2009;  Jang  et  al.,  2005).  Brd4  binds  to  acetylated  histones  and
represents a prevalent mechanism how P-TEFb is recruited to active genes (Hargreaves
et al., 2009; Yang et al., 2005). P-TEFb is also recruited by NF-κB (Barboric et al., 2001;
Luecke  and  Yamamoto,  2005),  the  viral  transactivator  Tat  (Price,  2000)  and  others
(Gargano et al., 2007; Oven et al., 2007).
The equilibrium between  the  active  and the  inactive  state  of  P-TEFb is  regulated  by
association with the small nuclear ribonucleic protein (snRNP) 7SK snRNP consisting of
7SK snRNA and the proteins HEXIM, LARP7 and MEPCE (Figure 5) (Chen et al., 2008;
Jeronimo et al., 2007; Markert et al., 2008; Peterlin and Price, 2006; Yik et al., 2003). P-
TEFb release from this inhibitory complex is controlled by various factors in response to
external stimuli  (Chen et al.,  2004; Li  et al.,  2005), such as the direct interaction with
transcriptional  coactivators  like  Brd4  or  the  HIV-1  Tat  protein  (Barboric  et  al.,  2007;
Krueger et al., 2010; Sedore et al., 2007; Tahirov et al., 2010; Yang et al., 2005).
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Figure 4: Models of possible mechanisms of promoter-proximal pausing. 
Adapted from  (Kwak and Lis,  2013).  Possible mechanisms that  impede Pol  II  elongation and
induce pausing.
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 3.4 Physiological significance of promoter-proximal pausing
Several biological functions of promoter-proximal pausing have been discussed (Adelman
and Lis, 2012; Chiba et al., 2010).
In addition to the highly regulated process of  transcription initiation,  promoter-proximal
pausing  provides  another  potential  for  the  regulation  and  synchronous  activation  of
genetic activity (Boettiger and Levine, 2009). Promoter-proximal pausing enables the cell
to perform transcription more flexible and elaborate.
Promoter-proximal pausing has first been observed at immediate-early genes which are
capable of rapid induction upon specific signals  (Aida et al., 2006; Krumm et al., 1992;
Rougvie  and  Lis,  1990).  PIC-assembly  at  the  promoter  site  is  a  relatively  slow and
complex multi-step process requiring a plethora of general and specific factors (Thomas
and Chiang, 2006). Conversely, once P-TEFb has been activated release of paused Pol II
is a fast process. It is hence speculated that promoter-proximal pausing circumvents the
time-consuming  assembly  of  the  transcription  machinery  and  facilitates  a  dynamic
regulation of genes that need to be activated quickly like heat shock factors (Andrulis et
al., 2000; Wu et al., 2003).
To prevent nascent pre-mRNA from fast degradation by exonucleases (Hsu and Stevens,
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Figure  5:  Overview  of  the  early transcription  phase  and the  factors  involved  in  initiation  and
promoter-proximal pausing. 
Blue circles indicate P-TEFb-mediated phosphorylation that are requisite for pause-release. Before
Pol-II  commences  stable  elongation,  phosphorylated  NELF  dissociates  and  elongation  factors
Paf1C and Tat-SF1 associate with Pol II.
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1993) the 5'  end is modified by the cap-binding complex (CBC) with a 5' guanylyl cap
(Gonatopoulos-Pournatzis  and  Cowling,  2014;  Hocine  et  al.,  2010;  Shuman,  2001).
Capping is coupled to transcription and occurs during the early elongation phase when
RNA reaches a length of 20-30 nt  (Martinez-Rucobo et al., 2015; Perales and Bentley,
2009; Yue et al., 1997). The CBC recruits elongation factors and during translation the cap
is  important  for  recognition  of  the mRNA by ribosomes  (Gonatopoulos-Pournatzis  and
Cowling,  2014;  Tarun  and Sachs,  1996).  The CBC was shown to  stimulate the  early
elongation phase (Kim et al., 2004), conversely NELF, DSIF and P-TEFb were observed
to interact with and regulate the CBC (Mandal et al., 2004; Narita et al., 2007; St Amour et
al., 2012; Wen and Shatkin, 1999). This links two important events in early elongation,
promoter-proximal  pausing  and  capping.  Thus  promoter-proximal  pausing  could  also
function as a checkpoint to ensure only correctly capped mRNA is fully transcribed.
The DNA sequence in promoter regions can affect their association with nucleosomes
(Gilchrist et al., 2010; Gilchrist et al., 2008; Iyer and Struhl, 1995; Kaplan et al., 2009;
Valouev et al., 2011). Nucleosome formation in the promoter region is often a feature of
highly regulated genes whereas promoters of housekeeping genes are free of chromatin
(Gilchrist et al., 2010). In promoter regions occupied by nucleosomes, promoter-proximal
pausing contributes to creating a nucleosome free region (NFR) keeping the promoter
permissive for binding of the transcription machinery and regulatory factors  (Gilchrist et
al.,  2010).  Indeed  promoter-proximal  pausing  causes  a  downstream  shift  of  the  +1
nucleosome (Schones et al., 2008). In contrast depletion of NELF results in a loss of the
NFR and a decrease of transcription rate at many genes (Gilchrist et al., 2008).
 4 Significance of NELF for the treatment of HIV infections
After entering a cell the HI virus reversely transcribes its RNA-genome and inserts the
generated DNA into the nuclear genome of the host cell. For viral replication, the DNA
again needs to be transcribed into RNA (Klimas et al., 2008). Transcription of HIV genes
starts at the long terminal repeat (LTR) region where the cellular transcription machinery
and  co-activators  are  recruited  (Rohr  et  al.,  2003).  Similar  to  many  cellular  genes,
elongation of Pol II is paused during the early elongation phase  (Ott et al., 2011). The
highly conserved sequence of the transactivation response element (TAR) is located at
the 5' end of the nascent viral transcript and forms a double-stranded stem loop. NELF-E
binds to the stem loop with high affinity and represses elongation  (Pagano et al., 2014;
Zhang et al., 2007). Consequently the transcription of viral genes remains inefficient and
14
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the HIV protein Tat is required to release this block. Tat-mediated recruitment of P-TEFb to
the pausing site results in resumption of productive elongation (Karn and Stoltzfus, 2012;
Ott et al., 2011; Zhou and Yik, 2006). Tat binds the TAR stem-loop displacing NELF and P-
TEFb phosphorylates the pausing complex as described above (Ott et al., 2011). The Tat
protein itself is encoded by the transcribed RNA, which triggers a positive feedback loop.
If Tat is mutated or Pol II pausing release is prevented by any other means, transcription
of HIV RNA continues to be unproductive, preventing HIV-1 replication and causing latent
infection. A latent viral infection poses a major problem to therapeutic eradication of a HIV
infection due to the absence of viral activity that can be targeted by drugs (Siliciano and
Greene, 2011). For that reason promoter-proximal pausing is also of medical relevance.
 5 Aims and scope
Although NELF is central to promoter-proximal pausing and involved in the regulation of
various important developmental and physiological processes in multicellular organisms,
no structural information is known except for the NELF-E RRM. NELF-E can bind to RNA;
however, it is unclear what molecular mechanism NELF uses to induce promoter-proximal
pausing. The origin and evolution of NELF is also unclear. In contrast to DSIF, which is
central  to  transcription  in  all  living  cells,  NELF  is  only  present  in  some  eukaryotes.
Sequence  alignments  have  identified  homologs  in  metazoans and a  subset  of  single
celled eukaryotes but not in yeast or plants.
High-resolution structures of  conserved regions of  the NELF complex or  of  the entire
complex would  provide new insights  into its  function,  overall  architecture,  and role  in
promoter-proximal pausing. Discovery of structural homologs could support the search for
the evolutionary origin of NELF.
The primary goal of this thesis was to crystallize the NELF complex and solve its stucture
in molecular detail. To this end the NELF complex had to be expressed, purified in high
quality and characterized  in vitro. Flexible regions had to be identified and truncated in
order to obtain stable and compact constructs likely to crystallize. An optimized NELF-AC
complex could finally be crystallized and the structure was solved with 2.8 Å resolution.
Once a high-resolution structure was obtained it  had to be analyzed biochemically  to
asses its function in promoter-proximal pausing. Bioinformatic analysis of  the structure
model revealed large positive patches across the surface. Using protein-ligand binding
assays  the  interaction  partner  was  identified  to  be  single  stranded  nucleic  acids.  To
identify surface residues involved in protein-nucleic acid interaction and its regulation a
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series of mutant proteins had to be generated and characterized. From this studies, a
nucleic acid binding face on NELF-AC previously unknown was discovered.
The third goal of this thesis was to describe the architecture of the holo-NELF complex.
For this purpose a purification protocol for the complete four-subunit NELF complex had to
be  established.  Testing  different  combinations  of  subunits  in  co-expression  enabled
purification  of  holo-NELF in good yield and quality.  The architecture was resolved by
crosslinking the complex and identification of the crosslinks by mass-spectrometry. Holo-
NELF was observed to form a linear complex as reported previously (Narita et al., 2003)
with both nucleic acid binding sites solvent accessible and located at opposite ends of the
complex.
Based on the information obtained during this thesis it was possible to propose a new
model how NELF contributes to establish promoter-proximal pausing and postulate that
NELF acts partially by binding nascent RNA via its NELF-A subunit close to the RNA-exit
tunnel.
In this study the first unique high-resolution structure of a NELF subcomplex could be
solved and a novel function be assigned. Thus all proteins involved in promoter-proximal
pausing are now structurally characterized to a substantial extent, providing the basis for
investigation of its mechanism on a molecular level.
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 1 Materials
 1.1 Bacterial strains
Table 3: Bacterial strains used in this study
Strain genotype Resistance Source
E. coli XL-1 
Blue
rec1A; endA1, gyrA96; thi-1; hsdR17; supE44; 
elA1; lac[F’proAB lacIqZDM 15 tn10(Tetr)]
Tetracycline Stratagene
E. coli BL21 
(DE3)RIL
B; F-; ompT; hsdS(rB- mB-); dcm+; Tetr; gal 
λ(DE3); endA; Hte [argU, ileY, leuW, Camr] 
Chloramphenicol Stratagene
 1.2 Plasmids, synthetic genes and oligonucleotides
 1.2.1 Plasmids
Table 4: Vectors used for this study
ID vector Insert tag a Comment
DP 1 pET28a NELF-A N-His b
DP 2 pOPIN-M NELF-B N-His-MBP b
DP 3 pET21b NELF-C b
DP 4 pOPIN-F NELF-E N-His c
DP 5 pET28a NELF-A6-188 N-His
DP 6 pET21b NELF-C36-590
DP 7 pET21b NELF-C183-590
DP 8 pET28a NELF-A - IRES - NELF-C N-His (at 
NELF-A)
DP 9 pET28a NELF-A6-188 - IRES - NELF-C36-590 N-His (at 
NELF-A)
DP 10 pET28a NELF-A mut R65Q, R66Q (6-188) N-His d
DP 11 pET28a NELF-A mut K146M, K161M, K168M, R175Q (6-
188)
N-His d
DP 12 pET28a NELF-A mut R65Q, R66Q, K146M, K161M, 
K168M, R175Q (6-188)
N-His d
DP 13 pET21b NELF-C mut R291Q, R315Q (183-590) d
DP 14 pET21b NELF-C mut K371M, K372M, K374M (183-590) d
DP 15 pET21b NELF-C mut K384M, K388M (183-590) d
DP 16 pET21b NELF-C mut R419Q, R506Q (183-590) d
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ID vector Insert tag a Comment
DP 17 pET21b NELF-C mut R291Q, R315Q, K384M, K388M, 
R419Q, R506Q (183-590)
d
DP 18 pET21b NELF-C mut K371M, K372M, K374M, K384M, 
K388M, R419Q, R506Q (183-590)
d
DP 19 pET21b NELF-C mut K371M, K372M, K374M, R291Q, 
R315Q, K384M, K388M, R419Q, R506Q (183-590)
d
DP 20 pET28a NELF-A mut T157D (6-188) N-His d 
DP 21 pET28a NELF-A mut T173D (6-188) N-His d
DP 22 pET21b NELF-C mut T285D (183-590) d
DP 23 pET21b NELF-C mut Y289E (183-590) d
DP 24 pET21b NELF-C mut T318D (183-590)
DP 25 pET21b NELF-C 36-183 d 
DP 26 pANY NELF-A fl e
DP 27 pANY NELF-B fl e
DP 28 pANY NELF-C fl e
DP 29 pET21b f
DP 30 pET28a f
DP 31 pOPIN-F
DP 32 pOPIN-M
DP 33 pET28a NELF-A6-182 N-His g
DP 34 pET28a NELF-A6-193 N-His g
DP 35 pET28a NELF-A6-202 N-His g
DP 36 pET28a NELF-A9-188 N-His g
DP 37 pET28a NELF-A20-188 N-His g
DP 38 pET28a NELF-A29-188 N-His g
DP 39 pET28a NELF-A36-188 N-His g
DP 40 pET21b NELF-C36-559 g
DP 41 pET21b NELF-C36-568 g
DP 42 pET21b NELF-C36-573 g
DP 43 pET21b NELF-C36-585 g
DP 44 pET21b NELF-C30-590 g
DP 45 pET21b NELF-C52-590 g
DP 46 pET21b NELF-C55-590 g
DP 47 pET21b NELF-C57-590 g
DP 48 pET28a NELF-A mut E111A, E112A, Q113A (6-188) g
DP 49 pET21b NELF-C mut E138A, E139A, E141A (36-590) g
DP 50 pET21b NELF-C mut Q270A, E271A, K272A (36-590) g
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ID vector Insert tag a Comment
DP 51 pET21b NELF-C mut E138A, E139A, E141A, K371A, 
K372A, K374A (36-590)
g
DP 52 pET21b NELF-C mut Q270A, E271A, K272A, K371A, 
K372A, K374A (36-590)
g
DP 53 pET21b NELF-C mut E138A, E139A, E141A, Q270A, 
E271A, K272A, K371A, K372A, K374A (36-590)
g
a N-"tag" indicates N-terminally attached tag
b synthetic gene, codon optimized for E. coli
c natural sequence from H. sapiens cDNA
d Protein used for fluorescence anisotropy experiments
e Template for molecular cloning
f Vector backbone for molecular cloning
g Protein used for crystallization experiments
 1.2.2 Primers
Table 5: Primers used in this study
ID Name Sequence 5' to 3'
DP54 NELFA_fl_fwd CGCGCGGCAGCCATATGCCTGGTCAACGTCG
DP55 NELFA_fl_rev GGTGGTGGTGCTCGAGTTATTTCAAGACACATTCGTCATTG
G
DP56 shNELF_B_Fwd AAGTTCTGTTTCAGGGCCCGATGTTTGCCGGACTGCAGG
DP57 shNELF_B_Rev ATGGTCTAGAAAGCTTTATTACAGAGGGGCAGGGGC
DP58 NELFC_fl_fwd GGAGATATACATATGGCAGGTGCTGTTCC
DP59 NELFC_fl_rev GCTCGAATTCGGATCCTCAGTTTACCATAATGAAGTTGCTTT
TACAGTGAG
DP60 NELF_E_Fwd AAGTTCTGTTTCAGGGCCCGATGTTGGTGATACCCCCCGG
ACT
DP61 NELF_E_Rev ATGGTCTAGAAAGCTCTAGAAGCCATCCACAAGGTTTTCCT
TGTAG
DP62 NELFA_R6_fwd CGCGCGGCAGCCATATGGAATCTGATACCGGTCTGTGGCT
G
DP63 NELF_A_Q188_rev GGTGGTGGTGCTCGAGTTATTGTTGGGCAGTCTCGGTTG
DP64 NELFC_E36_fwd GGAGATATACATATGGAAGGCGAAGATGATGCCGAG
DP65 NELFC_G183_fwd AGGAGATATACATATGGGATATCAAGG CGAGATCACCTCTG
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DP66 NELFA_fus_rev TATATCTCCTTCTTAAAGTTAAACAAAATTATTTCAAGACACA
TTCGTCATTGG
DP67 NELFC_fus_fwd TTTGTTTAACTTTAAGAAGGAGATATACCATGGCAGGTGCTG
TTCC
DP68 NELFC_E36_fus_
fwd
TTTGTTTAACTTTAAGAAGGAGATATACCATGGAAGGCGAAG
ATGATGCCGAGGTC
DP69 NELFA_Q188_fus_
rev
GGTATATCTCCTTCTTAAAGTTAAACAAATTATTGTTGGGCA
GTCTCGGTTG
DP70 NELFA_R65R66mut_
fwd
TGGGTACACTGCATCTGCCTCAACAGACTGTGGATGAAATG
AAAGG
DP71 NELFA_R65R66mut_
rev
CCTTTCATTTCATCCACAGTCTGTTGAGGCAGATGCAGTGT
ACCCA
DP72 NELFA_K146M_fwd TGGAATGTCAGTATCTGAACATGAACGCCCTGACTACACTG
GC
DP73 NELFA_K146M_rev GCCAGTGTAGTCAGGGCGTTCATGTTCAGATACTGACATTC
CA
DP74 NELFA_K161M_fwd GTCCTCTGACTCCACCTGTTATGCACTTCCAACTGAAACGT
AA
DP75 NELFA_K161M_rev TTACGTTTCAGTTGGAAGTGCATAACAGGTGGAGTCAGAG
GAC
DP76 NELFA_K168M_fwd AACACTTCCAACTGAAACGTATGCCGAAATCAGCGACACTG
CG
DP77 NELFA_K168M_rev CGCAGTGTCGCTGATTTCGGCATACGTTTCAGTTGGAAGTG
TT
DP78 NELFA_R175Q_fwd AACCGAAATCAGCGACACTGCAAGCCGAGCTGCTGCAAAA
ATC
DP79 NELFA_R175Q_rev GATTTTTGCAGCAGCTCGGCTTGCAGTGTCGCTGATTTCG
GTT
DP80 NELFC_R291Q_fwd GTACAGCCGCTTCTTATCCTCAAGCCTGTCAGGCCCTGGG
AGC
DP81 NELFC_R291Q_rev GCTCCCAGGGCCTGACAGGCTTGAGGATAAGAAGCGGCT
GTAC
DP82 NELFC_K315M_fwd CCGATATTACCGTACTGTTTATGATGTTCACCAGCATGGACC
C
DP83 NELFC_K315M_rev GGGTCCATGCTGGTGAACATCATAAACAGTACGGTAATATC
GG
DP84 KKNKmut_fwd CTAGTGTTGTGGAAACGTGGATGATGAACATGCGTGTGTCT
ATTAACAAAGA
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DP85 KKNKmut_rev TCTTTGTTAATAGACACACGCATGTTCATCATCCACGTTTCC
ACAACACTAG
DP86 KSTSKmut_fwd CTATTAACAAAGACGAACTGATGTCGACCAGCATGGCAGTG
GAGACTGTCCACAA
DP87 KSTSKmut_rev TTGTGGACAGTCTCCACTGCCATGCTGGTCGACATCAGTTC
GTCTTTGTTAATAG
DP88 NELFC_R419Q_fwd GTACACTGTATCAGTGTATTCAGTTCCCGGTTGTGGCAATG
GG
DP89 NELFC_R419Q_rev CCCATTGCCACAACCGGGAACTGAATACACTGATACAGTGT
AC
DP90 NELFC_R506Q_fwd GTATGGTACACCTGCTGTCTCAGGGTTATGTTCTGCCGGTT
GT
DP91 NELFC_R506Q_ref ACAACCGGCAGAACATAACCCTGAGACAGCAGGTGTACCA
TAC
DP92 NELFA_T157D_fwd CTACACTGGCAGGTCCTCTGGATCCACCTGTTAAACACTTC
CA
DP93 NELFA_T157D_rev TGGAAGTGTTTAACAGGTGGATCCAGAGGACCTGCCAGTG
TAG
DP94 T173Dmut_fwd AACGTAAACCGAAATCAGCGGACCTGCGCGCCGAGCTGCT
GCA
DP95 T173Dmut_rev TGCAGCAGCTCGGCGCGCAGGTCCGCTGATTTCGGTTTAC
GTT
DP96 NELFC_T285D_fwd AGATCACACTGGCTCTGGGTGACGCCGCTTCTTATCCTCGT
GC
DP97 NELFC_T285D_rev GCACGAGGATAAGAAGCGGCGTCACCCAGAGCCAGTGTG
ATCT
DP98 NELFC_Y289E_fwd CTCTGGGTACAGCCGCTTCTGAGCCTCGTGCCTGTCAGGC
CCT
DP99 NELFC_Y289E_rev AGGGCCTGACAGGCACGAGGCTCAGAAGCGGCTGTACCC
AGAG
DP100 NELFC_T285D_
Y289E_fwd
AGATCACACTGGCTCTGGGTGACGCCGCTTCTGAGCCTCG
TGCCTGTCAGGCCCT
DP101 NELFC_T285D_
Y289E_rev
AGGGCCTGACAGGCACGAGGCTCAGAAGCGGCGTCACCC
AGAGCCAGTGTGATCT
DP102 T318Dmut_fwd CCGTACTGTTTAAAATGTTCGACAGCATGGACCCACCACCT
GT
DP103 T318Dmut_rev ACAGGTGGTGGGTCCATGCTGTCGAACATTTTAAACAGTAC
GG
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ID Name Sequence 5' to 3'
DP104 T7_fwd TAATACGACTCACTATAGGG
DP105 T7_rev CTAGTTATTGCTCAGCGG
DP106 NELFA_S9_fwd CGCGCGGCAGCCATATGTCTCCGAAAATGGCCTCAATGC
DP107 NELFA_T20_fwd CGCGCGGCAGCCATATGACCGGTCTGTGGCTGCACA
DP108 NELFA_G29_fwd CGCGCGGCAGCCATATGGGTGCTACCGATGAACTGTGGG
DP109 NELFA_A36_fwd CGCGCGGCAGCCATATGGCTCCTCCGTCAATTGCTTCTCT
G
DP110 NELFA_S182_rev GCTCGAATTCGGATCCTCATGATTTCGGTTTACGTTTCAGTT
GGAAG
DP111 NELFA_S193_rev GCTCGAATTCGGATCCTCATGATTTTTGCAGCAGCTCGGC
DP112 NELFA_R202_rev GCTCGAATTCGGATCCTCAGCGTTTCAGTTGTTGGGCAGT
C
DP113 NELFC_N559_rev GCTCGAATTCGGATCCTCAGTTTTCCAGAATCGGCAGAAAC
AGC
DP114 NELFC_T568_rev GCTCGAATTCGGATCCTCAAGTTTTAATGGTGCCGGCAATG
C
DP115 NELFC_D573_rev GCTCGAATTCGGATCCTCAATCGTGCTCGCCTTCAGTTTTA
ATGG
DP116 NELFC_N585_rev GCTCGAATTCGGATCCTCAGTTGCTTTTACAGTGAGCAATG
AATTCGG
DP117 NELFC_Q30_fwd GGAGATATACATATGCAAGAGGACGATTCCGGTGAAG
DP118 NELFC_S52_fwd GGAGATATACATATGTCTACCCGTGACTATATCATGGAGCC
DP119 NELFC_D55_fwd GGAGATATACATATGGACTATATCATGGAGCCGAGCATTTTT
AACAC
DP120 NELFC_I57_fwd GGAGATATACATATGATCATGGAGCCGAGCATTTTTAACAC
DP121 NELFC_3Ecluster_
mut_fwd
GATTCCATTTTTACCGCAGCGGGCGCAACTCCAGCGTGGC
TGG
DP122 NELFC_3Ecluster_
mut_rev
CCAGCCACGCTGGAGTTGCGCCCGCTGCGGTAAAAATGGA
ATC
DP123 NELFC_QEKcluster
_mut_fwd
GGAAGTCCAACGCTTTGCCGCAGCGGCAGGGCATGATGCT
AGCCAGATCAC
DP124 NELFC_QEKcluster
_mut_rev
GTGATCTGGCTAGCATCATGCCCTGCCGCTGCGGCAAAGC
GTTGGACTTCC
DP125 NELFC_3Kcluster_
mut_fwd
CCTATGCTGCTAGTGTTGTGGAAACGTGGGCAGCAAACGC
ACGTGTGTCTATTAACAAAGACGAACTGAAATCG
DP126 NELFC_3Kcluster_
mut_rev
CGATTTCAGTTCGTCTTTGTTAATAGACACACGTGCGTTTGC
TGCCCACGTTTCCACAACACTAGCAGCATAGG
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ID Name Sequence 5' to 3'
DP127 NELFA1_EEQcluster
_mut_fwd
GTTCACTGAACCTGGAACTGGCAGCAGCGAATCCGAACGT
CCAAGAC
DP128 NELFA1_EEQcluster
_mut_rev
GTCTTGGACGTTCGGATTCGCTGCTGCCAGTTCCAGGTTC
AGTGAAC
 1.2.3 Genes
Table 6: Synthetic genes used in this study
Name organism comment
NELF-A H. sapiens synthetic, codon optimized for E. coli
NELF-B H. sapiens synthetic, codon optimized for E. coli
NELF-C H. sapiens synthetic, codon optimized for E. coli
 1.2.4 Nucleic acids for fluorescence anisotropy
Table 7: Nucleic acids used for fluorescence anisotropy experiments in this study
ID Name Type Sequence 5' to 3' Modification
DP 129 c-fos_RNA ssRNA CCGCAUCUGCAGCGAGCAUCUGAGA 5' 6-FAM
DP 130 junB_RNA ssRNA AGCGGCCAGGCCAGCCUCGGAGCCA 5' 6-FAM
DP 131 44%_RNA ssRNA ACCCCACAACUAAAAAAUCCCAACC 5' 6-FAM
DP 132 60%_RNA ssRNA AAGGGGAGCGGGGGAGGAUAAUAGG 5' 6-FAM
DP 133 72%_RNA ssRNA ACCACCCACCCACCCCACCGAACGC 5' 6-FAM
DP 134 c-fos_DNA ssDNA AAGACTGAGCCGGCGGCCGC 5' 6-FAM
DP 135 junB_DNA ssDNA AGGGAGCTGGGAGCTGGGGG 5' 6-FAM
DP 136 44%_DNA ssDNA ACCCCACAACTAAAAAATCCCAACC 5' 6-FAM
DP 137 60%_DNA ssDNA AAGGGGAGCGGGGGAGGATAATAGG 5' 6-FAM
DP 138 72%_DNA ssDNA ACCACCCACCCACCCCACCGAACGC 5' 6-FAM
DP 139 44%_rev_comp ssDNA GGTTGGGATTTTTTAGTTGTGGGGT
DP 140 60%_rev_comp ssDNA CCTATTATCCTCCCCCGCTCCCCTT
DP 141 72%_rev_comp ssDNA GCGTTCGGTGGGGTGGGTGGGTGGT
DP 142 40%_hybrid RNA:DNA 
hybrid
ACCCCACAACUAAAAAAUCCCAACC 5' 6-FAM a
DP 143 60%_hybrid RNA:DNA 
hybrid
AAGGGGAGCGGGGGAGGAUAAUAGG 5' 6-FAM a
DP 144 72%_hybrid RNA:DNA 
hybrid
ACCACCCACCCACCCCACCGAACGC 5' 6-FAM a
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ID Name Type Sequence 5' to 3' Modification
DP 145 44%_dsDNA dsDNA ACCCCACAACTAAAAAATCCCAACC 5' 6-FAM b
DP 146 60%_dsDNA dsDNA AAGGGGAGCGGGGGAGGATAATAGG 5' 6-FAM b
DP 147 72%_dsDNA dsDNA ACCACCCACCCACCCCACCGAACGC 5' 6-FAM b
a RNA strand is modified
b sense strand is modified
 1.3 Reagents and consumables
Table 8: Reagents and consumables used in this study
Type Source
Chemicals Merck (Darmstadt, Germany), Roth (Karlsruhe, Germany),
Sigma-Aldrich (Schnelldorf, Germany)
Enzymes, reagents and buffers for 
molecular cloning
Fermentas (St. Leon-Rot, Germany), NEB (Frankfurt am 
Main, Germany)
Oligonucleotides ThermoScientific (Ulm, Germany), biomers (Ulm, 
Germany), IDT DNA (Leuven, Belgium)
Synthetic genes Mr. Gene (Regensburg, Germany)
Commercial kits for DNA preparation Qiagen (Hilden, Germany)
Crystallization reagents and tools Hampton Research (Aliso Viejo, CA, USA), Qiagen 
(Hilden, Germany)
 1.4 Growth media and additives
Table 9: Bacterial growth media used in this study
Medium Description Application
Lysogeny 
broth (LB)
1 % (w/v) Tryptone; 0.5 % (w/v) Yeast extract;
1 % (w/v) NaCl
E. coli culture
LB plates 1 % (w/v) Tryptone; 0.5 % (w/v) Yeast extract;
1 % (w/v) NaCl; 1.5 % (w/v) agar; 1x Antibiotic
E. coli culture on plates
X-Gal plates 1 % (w/v) Tryptone; 0.5 % (w/v) Yeast extract;
1 % (w/v) NaCl; 1.5 % (w/v) agar; 1x Antibiotic; 0.02 % 
X-Gal dissolved in N,N-Dimethylformamide (DMF)
E. coli culture, selection of 
pOPIN vectors containing 
the correct insert
SeMet 
medium
Obtained from AthenaES Expression of seleno-
methionine-substituted 
proteins in E. coli
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Table 10: Growth media additives used in this study
Additive Concentration Application
Ampicillin 100 μg/ml Selection of E. coli
Kanamycin 30 μg/ml Selection of E. coli
Chloramphenicol 30 μg/ml Selection of E. coli
Tetracycline 12.5 µg/ml Selection of E. coli
IPTG 0.1 mM - 1.0 mM Induction of protein expression in E. coli
 1.5 Buffers and solutions
 1.5.1 General buffers, solutions and dyes
Table 11: General buffers, solutions and dyes used in this study
Name Composition/Source Application
50x TAE 250 mM EDTA; 12.5 M Tris-acetate, pH = 8.0 Agarose gel 
electrophoresis
TE 1 mM Tris, pH 8.0; 0.1 mM EDTA DNA storage
6x DNA-loading dye 1.5 g/L Bromphenol blue; 1.5 g/L Xylene cyanol; 50
% (v/v) Gylcerol (Fermentas)
Agarose gel 
electrophoresis
MOPS Electro-
phoresis buffer
NuPAGE buffer (life technologie) SDS-PAGE
5x SDS-loading 
buffer
10 % (w/v) SDS; 10 mM DTT; 20 % (v/v) glycerole;
0.2 M Tris-HCl, pH = 6.8; 0.05 % (w/v) 
Bromphenolblue
SDS-PAGE
Western blot transfer
buffer
25 mM Tris; 192 mM glycine; 20 % EtOH Western blot
Gel staining solution Instant blue (Expedion) Coomassie staining of 
PA gels
Thiosulfate solution 0.02 % sodium thiosulfate Silver staining of PA 
gels
Silver nitrate solution 0.1 % silver nitrate; 0.02 % formaldehyde Silver staining of PA 
gels
Developing solution 3 % sodium carbonate; 0.05 % formaldehyde Silver staining of PA 
gels
100x PI 1.42 mg leupeptin; 6.85 mg pepstatin A; 850 mg 
PMSF; 1.685 mg benzamidine in 50 ml ethanol
protein purification
Denaturating buffer 8 M urea; 1 M Tris pH = 8.0 Resuspension of TCA-
precipitated protein
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Name Composition/Source Application
TFB-I 30 mM KAcetate; 50 mM MnCl2; 100 mM RbCl;
10 mM CaCl2; 15 % (v/v) glycerol
Prepare chemically 
competent E. coli
TFB-II 10 mM MOPS, pH = 7.0; 75 mM CaCl2;
10 mM RbCl; 15 % (v/v) glycerol
Prepare chemically 
competent E. coli
 1.5.2 Protein purification buffers
Table 12: Buffers used for protein purification in this study
Name Composition Application
Lysis buffer A 150 mM NaCl; 40 mM Na-HEPES pH 7.4 at 
4°C; 10 mM imidazole; 2 mM DTT; 1x PI
NELF-AC purification
Lysis buffer B 250 mM NaCl; 40 mM Na-HEPES pH 7.4 at 
4°C; 10 mM imidazole; 2 mM DTT; 1x PI
NELF-ABC purification
Lysis buffer C 500 mM NaCl; 40 mM Na-HEPES pH 7.4 at 
4°C; 10 mM imidazole; 2 mM DTT; 1x PI
NELF-E purification
Dialysis buffer A 150 mM NaCl; 40 mM Na-HEPES pH 7.4 at 
4°C; 2 mM DTT
NELF-AC purification
Dialysis buffer B 500 mM NaCl; 40 mM Na-HEPES pH 7.4 at 
4°C; 2 mM DTT
NELF-E purification
Washing buffer 
MBP
300 mM NaCl; 40 mM Na-HEPES pH 7.4 at 
4°C; 10 % glycerole; 2 mM DTT
NELF-ABC purification
Elution buffer 
MBP
300 mM NaCl; 40 mM Na-HEPES pH 7.4 at 
4°C; 10 % glycerole; 2 mM DTT; 40 g/l maltose
NELF-ABC purification
Ion exchange low/
high salt buffer
100/1000 mM NaCl; 40 mM Na-HEPES pH 7.4 
at 4°C; 2 mM DTT
Ion exchange 
chromatography
Size exclusion 
buffer A
150 mM NaCl; 10 mM Na-HEPES pH 7.4 at 
4°C; 2 mM DTT
Size exclusion 
chromatography of NELF-AC
for crystallization
Size exclusion 
buffer B
500 mM NaCl; 10 mM Na-HEPES pH 7.4 at 
4°C; 2 mM DTT
Size exclusion 
chromatography of complete-
NELF
Size exclusion 
buffer C
50 mM NaCl; 10 mM Na-HEPES pH 7.4 at 4°C;
2 mM DTT
Size exclusion 
chromatography of NELF-AC
for fluorescence anisotropy
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 1.5.3 Fluorescence anisotropy buffers
Table 13: Buffers used for fluorescence anisotropy
Name Composition Application
Dilution buffer 50 mM NaCl; 40 mM Na-HEPES pH 7.4 at 4°C;
2 mM DTT
Serial dilution of 
protein
2.5x buffer 12.5 mM NaCl; 12.5 mM Na-HEPES pH 7.4;
7.5 mM MgCl2; 2.5 mM DTT; 125 µg/ml BSA
Adjustment of final 
concentrations
 1.5.4 Crosslinking buffers and solutions
Table 14: Buffers used for crosslinking
Name Composition Application
Crosslinking 
solution
disuccinimidyl suberate (DSS) 50 mM solution in DMSO 
prepared immediate before use, life technologies
Crosslinking
Quenching 
solution
1 M ammonium bicarbonate Crosslinking
 1.6 Crystallization screens
Table 15: 96-well high-throughput crystallization screens used in this study
Screen Source
AJ1 in-house productiona
AJ2 in-house productiona
Complex screen in-house productiona
Complex screen 2 in-house productiona
Crystal platform Magic 1 in-house productiona
Crystal platform Magic 2 in-house productiona
Morpheus in-house productiona
Wizars I II in-house productiona
Hampton research Index Hampton
Qiagen Classics Suite Qiagen
Qiagen Cryos Suite Qiagen
Qiagen JCSG+ Suite Qiagen
Qiagen PACT Suite Qiagen
Qiagen PEGs Suite Qiagen
a  In-house  production  of  the  Crystallization  Facility  at  the  Max  Planck  Institute  of
Biochemistry (Martinsried, Germany).
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 2 Methods
 2.1 Molecular cloning
Polymerase chain reaction
All inserts for molecular cloning were amplified by polymerase chain reaction (PCR) from
codon optimized, synthetic genes (Mr. Gene) (NELF-A, -B and -C) or  H.sapiens cDNA
(NELF-E).  PCR  programs  comprised  35  cycles  (Biometra  T3000  Thermocycler).
Annealing  temperature  and  elongation  time  were  adjusted  to  the  respective  required
conditions of the primers and template.
Primers were designed using the online NEB Tm-calculator (www.tmcalculator.neb.com)
and optimized for an annealing temperature of 55°C in the complementary region. Primers
used for molecular cloning contained an 5' overhang of 12 or 15 nt including the restriction
site for conventional or ligation independent cloning (LIC), respectively, followed by the
sequence complementary to the gene of interest. Tags and protease cleavage sites were
introduced by in-frame cloning into a suitable vector.
For fragment amplification 2x Phusion High Fidelity PCR Master Mix (NEB) was used with
a final primer concentration of  500 nM and 50 ng of pure DNA template in 50 µl final
volume.
For colony PCR Thermus aquaticus  (Taq)  DNA polymerase (Fermentas) was used with
final primer and Mg2+ concentrations of 640 nM and 2.5 mM, respectively, in 25 µl total
volume according to the manufacturers instructions. Single E. coli colonies were picked to
be used as template, resuspended in the complete reaction mix and additionally streaked
on a LB-plate containing the appropriate antibiotic. Colonies containing the correct insert
were later retrieved from this LB-plate.
Mutant genes were generated by amplifying two overlapping PCR products containing the
mutant site in the overlapping region at the 3' and 5' end of the sense strand, respectively.
In a second step both fragments were joined by fusion PCR.
PCR products were visualized by electrophoretic separation in a PerfectBlue Gelsystem
electrophoresis chamber using 0.5-1 % agarose gel and staining with  Sybr Safe diluted
1:10,000 (Invitrogen). Purification of PCR products from agarose gels was carried out us-
ing the QIAquick gel extraction kit (Qiagen).
Restriction and ligation
Vectors and inserts were digested with restriction endonucleases (NEB) according to the
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manufacturers manual and purified with QIAquick PCR purification kit  (Qiagen). 40 ng
vector and a seven-fold molar excess of insert were ligated using T4 DNA ligase (NEB) in
20 µl reaction volume according to the manual. Cloning into pOPIN vectors was done by
ligation independent cloning (LIC) using the InFusion Kit (Clontech) in 10 µl total volume
according to the manufacturers manual.
Preparation and transformation of competent cells
Two strains of chemically competent E. coli  cells were used for transformations. Ligation
products and plasmids (for  amplification)  were transformed into  XL1-Blue.  For  protein
overexpression  from  the  correspondent  plasmids  BL21-CodonPlus(DE3)-RIL  were
employed (Table 3).
To prepare chemically competent cells 400 ml of LB including the appropriate antibiotic
were inoculated 1:100 with cells from an ON LB-culture, grown at 37°C until OD600  ~ 0.5
and  cooled  down  on  ice  to  stop  growth.  Subsequently  cells  were  harvested  by
centrifugation for 10 min at 4°C and 4000 rpm, resuspended in 100 ml prechilled TFB-I on
ice and centrifuged as before. The pellet was resuspended in 8 ml prechilled TFB-II on
ice. 50 µl aliquots were flash frozen in liquid nitrogen and stored at -80°C.
100 ng of each pure plasmid, 4 µl ligated plasmid or 2.5 µl InFusion product, respectively,
were transformed into chemically competent cells by heat shock. 50 µl cells were thawed
on ice and incubated with DNA for 20 min on ice followed by 45 sec at 42°C and 2 min on
ice. Subsequently 450 µl of LB were added and the cells shaken for 1 h at 37°C. Cells
were spread on selective LB- plates and grown ON at 37°C.
Plasmid verification, preparation and storage
Bacterial  colonies containing a plasmid with an insert  were verified by colony-PCR as
described and incubated ON in 10 ml LB. Plasmids were prepared from this ON cultures
using Miniprep purification kits (Qiagen). To obtain glycerol stocks 500 µl of an ON culture
were mixed with 500 µl glycerole and stored at -80°C.
 2.2 Protein methods
 2.2.1 General protein methods
Protein analysis methods
For sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) the NuPAGE
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system (life technologies) was employed using 4-12 % gradient  gels.  Protein samples
were mixed with 5x SDS-loading buffer to a final concentration of 1x and incubated for 3
min  at  95°C.  SDS-PAGE  Molecular  Weight  Standard  Broad  Range  (Bio-Rad)  and
PageRuler  Prestained  Protein  Ladder  (Fermentas)  were  used  as  molecular  weight
standards. Gels were developed in 1x MOPS buffer at 200 V until the dye reached the
lower end of the gel and stained with instant blue (Expedeon).
In case of low protein concentration TCA-precipitation was performed before SDS-PAGE
analysis. Trichloroacetic acid (TCA) was added to a final concentration of 10 %, incubated
on ice for  20 min and centrifuged at  15000 rpm and 4°C for  15 min.  The pellet  was
washed twice with prechilled (-20°C) acetone on ice, dried at 50°C and resuspended in 12
µl denaturating buffer.
Trace amounts of protein on a PA gel were detected by silver staining. The PA gel was
washed in ddH2O thoroughly and incubated in thiosulfate solution for 1 min. After washing
3x20 sec with ddH2O the gel was incubated in silver nitrate solution for  20 min. After
washing  3x20 sec  with  ddH2O the gel  was  incubated  in  developing  solution  until  the
protein bands were visible and the reaction stopped with 5 % (v/v) acetic acid.
Protein concentration was determined with a NanoDrop 1000 spectrophotometer (Peqlab)
using  protein  specific  parameters  regarding  the  molar  attenuation  coefficient  ε and
molecular weight.
Dynamic light scattering (DLS) was done with a Viscotek 802 DLS (Malvern Instruments)
and the result analysed with the OmniSIZE software.
Limited proteolysis and fragment identification
Limited proteolysis was employed to identify stable fragments of proteins that were more
likely to form crystals. 30 µg of protein in 100 µl total reaction volume were incubated at
37°C with varying amounts of  protease (chymotrypsin or  subtilisin)  in  order  to ensure
observable and complete degradation of flexible regions within 30 min. Samples of 12 µl
volume were taken at varying points in time and the reaction stopped by immediate mixing
with 3µl 5x SDS-loading dye and incubation at 95°C for 3 min. Degradation products were
analysed by PAGE, transferred to a PVDF-membrane by Western blot (35 V, ON) and
identified by Edman-Sequencing at the Max Planck Institute of Biochemistry core facility
(Martinsried,  Germany).  Unknown protein bands were identified by MALDI-MS peptide
mass fingerprinting at the Adolf  Butenandt Institut, Zentrallabor für Proteinanalytik (ZfP)
(Munich, Germany).
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 2.2.2 Purification of recombinant proteins
NELF-A6-188C36-590 and NELF-A6-188C183-590
The borders of NELF-A and NELF-C within the NELF-AC subcomplex were determined by
limited proteolysis of human full-length NELF-AC complex with chymotrypsin and subtilisin
followed by Edman sequencing. Human NELF-A and NELF-C were amplified from codon
optimized DNA (Mr. Gene) and cloned into pET28a and pET21b vectors, between NdeI
and XhoI or NdeI and BamHI restriction sites, respectively, resulting in N-terminally His6-
tagged NELF-A (6-188) and untagged NELF-C (36-590 or 183-590).
Plasmids  encoding  NELF-A  (6-188)  and  NELF-C  (36-590  or  183-590)  were  co-
transformed into E. coli BL21 CodonPlus (DE3) RIL cells. Cells were grown in LB medium
at 37°C until OD600 ~0.6 and cooled on ice for 30 minutes. Protein expression was induced
by the addition of 1 mM IPTG. After induction, cells were grown for an additional 16 hrs at
18°C. All purification steps were performed at 4°C. Cells were resuspended and lysed in
lysis buffer A including 1x protease inhibitor. The lysate was applied to Ni-NTA agarose
beads (Qiagen)  and washed extensively with lysis  buffer  A containing  20 and 40 mM
imidazole.  Protein  was  eluted  from the  beads  with  lysis  buffer  A containing  200  mM
imidazole.  The  eluted  protein  was  mixed  with  1  U  thrombin/mg  protein  (Sigma)  and
dialyzed against dialysis buffer A for 16 hrs at 4°C. The protein was applied to Ni-NTA
beads equilibrated in  dialysis  buffer  A to remove uncleaved protein.  The Ni-NTA flow
through was applied to an anion exchange column (HiTrap Q-HP, 1 ml, GE Healthcare)
equilibrated in ion exchange low salt buffer. Protein was eluted via a salt gradient from
100 mM (low salt) to 1 M NaCl (high salt) in ion exchange buffer. The protein was further
purified by size exclusion chromatography with the use of a Superose 6 10/300 column
(GE Healthcare) equilibrated in size exclusion buffer A. Peak fractions were pooled and
concentrated by centrifugation in Amicon Ultra 4 ml concentrators (30 kDa and 10 kDa
MWCO, respectively) (Millipore) to 6 mg/ml (NELF-A6-188C36-590) and 12 mg/ml (NELF-A6-
188C183-590), respctively. Protein concentration was determined as described in 2.2.1. Protein
was aliquoted, flash frozen, and stored at -80° C. 
Selenomethionine-labeled protein NELF-A6-188C183-590
For  production  of  selenomethionine-labeled  protein,  NELF-AC  (6-188  and  183-590)
plasmids were co-transformed into E. coli  B834(DE3) cells. For protein expression, cells
were  grown  in  SelenoMet  Medium  (Table  9)  supplemented  with  40  µg/ml  L-
selenomethionine (SeMet). Selenomethionine-labeled protein was purified as above. 
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NELF-A6-188C36-590  mutant poteins
All NELF-A6-188C36-590 mutant poteins were purified like the wildtype protein.
NELF-ABC and ABCE
Human NELF-B (1-580) was cloned into a pOPIN-M-vector (Berrow et al., 2007) (provided
by OPPF-UK) to produce a N-terminally His6-MBP-tagged protein. Bicistronic expression
plasmids containing full-length His6-tagged NELF-A and NELF-C or His6-tagged NELF-A
(6-188) and NELF-C (36-590) were produced in the pET28a background between  NdeI
and  XhoI sites.  Full  length NELF-E was cloned into a pOPIN-F-vector  (Berrow et  al.,
2007) (provided by OPPF-UK) resulting in a protein with N-terminal His6-tag. All protein
expressions  were  performed  as  described  above  for  the  NELF-AC  constructs.  All
purification steps were performed at 4°C and protease inhibitor was used during lysis only.
NELF-E was purified in  lysis  buffer  C using  Ni-NTA chromatography as described for
NELF-AC.  Protein  was  dialyzed  against  dialysis  buffer  B  for  16  hrs  at  4°C  and
simultaneously  the  His-tag  was  cleaved  by  3C  protease.  Uncleaved  protein  and  3C
protease were removed by a second Ni-NTA chromatography step. NELF-E was further
purified by heparin affinity chromatography using a salt gradient from 100 mM to 1 M NaCl
in ion exchange buffer.
The full-length and truncated NELF-ABC complexes were obtained by coexpression of
full-length or truncated NELF-AC from a bicistronic vector together with full-length NELF-
B.  The  complex  was  purified  by  Ni-NTA in  lysis  buffer  B  and  amylose  resin  affinity
chromatography (NEB) in washing buffer MBP. Protein was eluted from amylose resin with
elution buffer MBP and diluted with water to achieve a final salt concentration of 150 mM
NaCl. The complex was purified further by anion exchange chromatography (HiTrap Q-HP,
1 ml, GE Healthcare) as described for NELF-AC, and the salt concentration was adjusted
to 500 mM NaCl. To remove the His6-MBP -tag from NELF-B, the complex was incubated
with 3C protease for 16 hrs at 4ºC. To obtain full-length and truncated NELF complexes,
an excess of heparin-purified NELF-E was added to pure NELF-ABC prior to cleavage of
the His6-MBP- tag from NELF-B. Both the NELF-ABC and complete NELF complex were
then applied to a Superose 6 10/300 size exclusion column equilibrated in size exclusion
buffer B. Truncated NELF-ABC and complete NELF were concentrated by centrifugation
to 2.1 mg/ml and 3.3 mg/ml, respectively, using Amicon Ultra 4 ml Centrifugal Filters (50
kDa MWCO) (Milipore), flash frozen, and stored at -80°C.
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 2.2.3 Protein interaction studies
Popin-M vector containing full length His-MBP-NELF-B was transformed into E. coli BL21
CodonPlus  (DE3)  RIL  cells.  NELF-B  was expressed  and  purified  by  Ni-NTA
chromatogaphy as described above. His-MBP-NELF-B was bound to amylose resin and
incubated for 16 hrs at 4°C with NELF-AC or NELF-C constructs NELF-A6-188C36-590, NELF-
A6-188C183-590,  NELF-C36-190 and  NELF-C183-590 which  have  been  purified  by  Ni-NTA as
described above for NELF-A6-188C36-590 and NELF-A6-188C183-590. After incubation the resin
was washed extensively with washing buffer MBP, eluted with elution buffer MBP and the
eluate analyzed by PAGE.
 2.3 X-Ray crystallography
 2.3.1 Crystallization screens of NELF-A6-188C36-590
Screens to find initial crystallization conditions for NELF-A6-188C36-590 were conducted at the
crystallization facility of the Max Planck Institute of Biochemistry (Martinsried, Germany)
using 96-well high throughput screens from Hampton, Qiagen and in-house productions
(Table 15). Screens were set up using a nanoliter crystallization robot (Phoenix) by mixing
each 100 nl protein and reservoir solution. Extensive screening yielded conditions that
were used as starting point.  Initial crystals were improved manually in 24-well hanging
drop plates (VDX plates with sealant, Hampton, 0.5 ml reservoir volume) by varying pH,
concentrations of salt and precipitant, temperature from 4°C – 20°C and drop size from
0.5 – 4 µl. Thin needle shaped crystals grew within 3-5 days in 1.1 – 1.2 M (NH4)2SO4, 0.2
M NaCl and 100 mM Na-HEPES pH 7.4.
 2.3.2 Crystallization screens and optimization of NELF-A6-188C183-590
Screens to  find  crystallization  conditions  for  NELF-A6-188C183-590 were  conducted  at  the
crystallization facility of the Max Planck Institute of Biochemistry (Martinsried, Germany)
using 96-well  high throughput screens from Hampton, Qiagen and in-house production
(Table 15). Screens were set up using a nanoliter crystallization robot (Phoenix) by mixing
each  100  nl  protein  and  reservoir  solution.  Extensive  screening  yielded  a  suitable
crystallization condition to produce well-diffracting crystals. Initial crystals were optimized
manually in 15-well EasyXtal hanging drop vapor diffusion plates (Qiagen, 0.2 ml reservoir
volume) by varying pH, concentrations of salt and precipitant, temperature from 4°C –
20°C and drop size between 0.5 and 4 µl.
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Optimized  native  and  selenomethionine-labeled NELF-AC  crystals  were  grown  by
hanging-drop vapor diffusion and obtained by mixing 1µl NELF-AC protein (12 mg/ml) with
1  µl  reservoir  solution  containing  14-14.5  %  (w/v)  PEG  3350  and  200  mM  sodium
malonate pH 6.8-7.0.  Tetrahedral NELF-AC crystals grew within 3-5 days. Crystals were
cryo-protected in mother liquor containing 25 % (w/v) glucose, and flash frozen in liquid
nitrogen.
 2.3.3 Data collection and processing
Diffraction data for native NELF-A6-188C183-590  crystals were collected under cryo conditions
(100 K)  in  0.1°  increments  at  beamline  X06DA of  the  Swiss  Light  Source  in  Villigen
(Switzerland) using a wavelength of  1.0000 Å and a Pilatus 2M-F detector (Table  17)
(Broennimann et al., 2006).
Raw data  were processed and scaled  with XDS.  The structure was solved by  single
isomorphous replacement with anomalous scattering (SIRAS) using diffraction data from
an isomorphous crystal of SeMet-labeled protein. Location of 13 selenomethionine sites,
calculation of initial phases and density modification were performed with the SHELX suite
(Sheldrick, 2008). An initial model was built with Buccaneer  (Cowtan, 2006). The model
was iteratively built with COOT  (Emsley and Cowtan, 2004) and refined with REFMAC
(Vagin et al., 2004) and phenix.refine (Afonine et al., 2005) until the R-factors converged
(Table 17). 
 2.4 Identification of P-TEFb in-vivo phosphorylation sites on 
NELF-A6-188C183-590
All experiments described in chapter II 2.4 were conducted by Seychelle M. Vos (NELF-
AC phosphorylation by P-TEFb) and Henning Urlaub (Phosphopeptide enrichment and
LC-MSMS analysis), both members of the MPI for Biophysical Chemistry, Goettingen.
NELF-AC phosphorylation by P-TEFb
Human Cdk9 (1-372) and Cyclin T1 (1-272) were co-expressed in High 5 insect cells and
purified as described (Schulze-Gahmen et al., 2013). NELF-A6-188C183-590 (10-200 µM) and
P-TEFb (0.4-2 µM) were incubated for 4-16 hrs at 30 ºC in a buffer containing 3-10 mM
ATP, 3-15 mM MgCl2, 1 mM DTT, 30 mM Na-HEPES pH 7.4, 4 % (v/v) glycerol, and 100
mM NaCl. The kinase-treated NELF-AC protein (100-500 pmol) was analyzed on a 4-12
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% Bis-Tris acrylamide gel and submitted for mass spectrometry.
Phosphopeptide enrichment and LC-MSMS analysis
Phosphopeptides derived after in-gel digest of the sample were enriched as described
previously  (Oellerich et al.,  2009). Enriched phosphopeptides were analyzed on a LC-
coupled  Q-Exactive  HF  mass  spectrometer  (ThermoFisherScientific)  under  standard
chromatography conditions as described (Oellerich et al., 2009). The MS raw files were
processed by MaxQuant  (Cox and Mann, 2008) (version 1.5.2.8)  and MS/MS spectra
were searched against Uniprot human database with Andromeda (Cox et al., 2011) search
engine. Allowed variable modifications included phosphorylation of serine, threonine, and
tyrosine, methionine oxidation, and carbamidomethlyation of cysteine.
 2.5 Fluorescence anisotropy 
All experiments described in chapter  II 2.5 were planned and conducted in cooperation
with Seychelle M. Vos.
Preparation of mutant proteins
WT and  mutant  NELF-A6-188C183-590 proteins  (Table  4)  were  expressed and  purified  as
described above (II 2.2.2). For the final size exclusion step, the column was equilibrated in
size exclusion buffer C. Peak fractions were pooled, concentrated by centrifugation to 30
mg/ml, aliquoted, flash frozen, and stored at -80ºC.
Nucleic acids
5'  6-FAM  labeled  ssDNA,  ssRNA and  dsDNA were  obtained  from  Integrated  DNA
Technologies and dissolved in water to 100 µM. Sequences of artificial ssDNA and dsDNA
with 44 %, 60 % and 72 % GC content are listed in Table 7 (corresponding sequences for
ssRNA). Natural ssDNA sequences correspond to sequences of exposed coding (non-
template) strands at the c-fos gene (‘DP 134’, bps 87-96 downstream of the TSS (Fivaz et
al., 2000)) and the junB gene (‘DP 135’, bps 45-54 downstream of the TSS (Aida et al.,
2006)) during  promoter-proximal  pausing  +/-5  bps  (Figure  14E).  Natural  ssRNA
sequences correspond to 25 nt of nascent mRNA sequence predicted to be proximal to
the RNA exit pore on the Pol II surface at c-fos (‘DP 129’, bps 53-77 relative to TSS) and
junB (‘DP 130’, bps 13-37 relative to TSS) during promoter-proximal pausing (Figure 14E).
To produce RNA-DNA hybrids, labeled ssRNA template was mixed at a 1:1 molar ratio
with reverse complementary ssDNA (Thermo Fisher Scientific), heated to 95° for 10 min
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and cooled down at a rate of 0.1°/min.
Assays
NELF- A6-188C183-590 was serially diluted in 2-fold steps in dilution buffer (Table 13). Nucleic
acid (2.4µl, 10nM final concentration) and NELF-AC (12µL, 100-0.1µM final concentration)
were mixed on ice and incubated for 10 minutes. The assay was brought to a final volume
of 24 µl 2.5x buffer (Table 13) and incubated for 20 min at RT in the dark (final conditions:
30 mM NaCl, 3 mM MgCl2, 10 mM Na-HEPES 7.4, 2 mM DTT and 50 µg/ml BSA). 20 µl of
each solution was transferred to a Greiner 384 Flat Bottom Black Small volume plate.
Measurement and evaluation
Fluorescence  anisotropy  was  measured  at  30°C  with  an  Infinite®  M1000Pro  reader
(Tecan) with an excitation wavelength of 470 nm (±5 nm), an emission wavelength of 518
nm (±20 nm) and a gain of 72. All experiments were done in triplicate and analyzed with
GraphPad Prism Version 6. Binding curves were fit with a single site quadratic binding
equation:
y=(
Bmax∗ ([x ]+[L]+Kd ,app− √([x ]+[L ]+Kd , app)2− 4([x ]∗ [L ]))
2∗ [L]
)
where Bmax is the maximum specific binding, L is the concentration of nucleic acid, x is
the concentration of NELF-A6-188C183-590, Kd,app is the apparent disassociation constant for
NELF- A6-188C183-590 and nucleic acid. Error bars (Figure 14,  Figure 15,  Figure 18,  Figure
26,  Figure  27)  are  representative  of  the  standard  deviation  from  three  experimental
replicates.
 2.6 Crosslinking and mass spectrometry
Crosslinking with disuccinimidyl suberate (DSS)
Truncated NELF-ABC complex and complete NELF complex were incubated with 1.0 mM
and 1.1 mM DSS H12/D12 (Creative Molecules), respectively,  for 30 min at 30°C. The
crosslinking  reaction  was  quenched  by  adding  ammonium  bicarbonate  to  a  final
concentration of 100 mM and incubation for 20 min at 30°C (Table 14).
Mass spectrometry identification of lysine-lysine crosslinking sites
All  experiments  described  in  this  paragraph were  performed  by  Tomasz Zimniak  and
Franz Herzog, both members of the Gene Center, LMU Munich.
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The chemical cross-links on NELF complexes were identified by mass spectrometry as
described previously (Herzog et al., 2012). Briefly, cross-linked complexes were reduced
with 5 mM TCEP (Thermo Scientific) at 35°C for 15 min and subsequently treated with 10 
mM iodoacetamide (Sigma-Aldrich) for 30 min at room temperature in the dark. Digestion
with lysyl enodpeptidase (Wako) was performed at 35°C, 6M Urea for 2 h (at enzyme-
substrate  ratio  of  1:50  w/w)  and  was  followed  by  a  second  digestion  with  trypsin
(Promega)  at  35°C overnight  (also  at  1:50  ratio  w/w).  Digestion  was stopped  by  the
addition of 1 % (v/v) trifluoroacetic acid (TFA). Acidified peptides were purified using C18
columns  (Sep-Pak,  Waters).  The  eluate  was  dried  by  vacuum  centrifugation  and
reconstituted in water/acetonitrile/TFA, 75:25:0.1. Cross-linked peptides were enriched on
a Superdex Peptide PC 3.2/30 column (300 × 3.2 mm) at a flow rate of 25 μl min−1 and
water/acetonitrile/TFA, 75:25:0.1 as a mobile phase. Fractions of 100 μl were collected,
dried, and reconstituted in 2 % acetonitrile and 0.2 % FA, and further analyzed by liquid
chromatography coupled to tandem mass spectrometry using a hybrid LTQ Orbitrap Elite
(Thermo  Scientific)  instrument.  Cross-linked  peptides  were  identified  using  xQuest
(Walzthoeni et al., 2012). False discovery rates (FDRs) were estimated by using xProphet
(Walzthoeni et al., 2012). and results were filtered according to the following parameters:
FDR = 0.05, min delta score = 0.90, MS1 tolerance window of -4 to 4 ppm, ld-score > 22.
 2.7 Bioinformatic tools
ClustalW  (Larkin  et  al.,  2007) was  used  to  produce  multiple  sequence  alignments.
Secondary structure predictions and analysis were done with Hhpred (Soding, 2005) and
psipred (Buchan et al., 2013). DNA and protein sequences were obtained from the NCBI´s
database and www.uniprot.org, respectively.  Protein specific parameters were calculated
using the ProtParam software  (Wilkins et al., 1999). For protein domain predictions we
used the NCBI´s conserved domain database (Marchler-Bauer et al., 2011). To predict
cluster of  surface amino acids  suitable for surface entropy reduction we employed the
SERp server  (http://services.mbi.ucla.edu/SER/)  (Goldschmidt  et  al.,  2007).  The  DALI
server  (Holm  and  Rosenstrom,  2010) was  used  for  structure  similarity  searches.
Evaluation of binding affinity data obtained by fluorescence anisotropy was conducted by
Prism 6.0 (see II 2.5). Pymol was used to visualize and investigate molecular models and
to produce images. Crystallography software tools were used as described in II 2.3.3.
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 III Results and discussion
 1 Structure and function of a truncated NELF-AC subcomplex 
and architecture of complete NELF
Data presented in chapter III 1 have been obtained during this thesis and were submitted
for publication (see page IV).
 1.1 NELF subcomplex NELF-AC
In a long-standing effort to obtain structural information on the intrinsically flexible NELF
complex, we delineated regions in human NELF subunits that form soluble subcomplexes
amenable to structural analysis (Figure 6, Figure 24, Figure 25, Table 16, II 2.2.2, III 2.1).
Bacterial co-expression of NELF subunit variants revealed that the N-terminal region of
NELF-A could be co-purified with NELF-C. Limited proteolysis and co-expression analysis
with  truncated  protein  variants  showed  that  the  N-terminal  residues  6-188  of  human
NELF-A and residues 183-590 of human NELF-C formed a stable subcomplex (‘NELF-
AC’). Purified NELF-AC could be crystallized by vapor diffusion, and the X-ray structure
was  solved  by  SIRAS  (Figure  7,  II  2.3).  The  structure  contained  one  NELF-AC
heterodimer in the asymmetric unit and was refined to a free R-factor of 25.6 % at 2.8 Å
resolution (Table 17). The structure shows very good stereochemistry and lacks only the
mobile NELF-A residues 183-188, and NELF-C residues 183-185, 401-402, 445-448, 523,
and 564-572.  In  the  final  model,  98.2  % of  residues  are in  preferred  Ramachandran
regions and 1.8 % of residues are in additionally allowed regions.
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Figure 6: Iterative truncation of full-length NELF-AC yields a variant amenable to crystallization
(A) Crystallized variant and previously identified functional regions in human NELF-A and NELF-C.
Cleavage sites of chymotrypsin and subtilisin are indicated by black and green arrows, respectively.
‘NELF-C’  delineates  the  previously  identified  NELF-C-binding  region  in  NELF-A  (Narita  et  al.,
2003), whereas ‘Pol II’ marks the region in NELF-A that associates with Pol Il (Narita et al., 2003).
(B) Partial digestion of pure full-length NELF-AC with chymotrypsin yields three stable degradation
products that were identified as NELF-A N-terminal domain (residues 6-188), NELF-A C-terminal
region  (residues  248-~485)  and  NELF-C  (residues  52-590).  The  resulting  truncated  construct
NELF-A6-188C36-590 did not yield diffracting crystals. Shown are SDS-PAGE analyses.
(C) Partial  digestion of  pure full-length NELF-AC and truncated NELF-A6-188C36-590 with subtilisin
yield the same stable degradation products for NELF-A (residues 6-188) and NELF-C (residues
190-590). 
(D)  The  resulting  truncated  variant  NELF-A6-188C183-590 (‘NELF-AC‘)  was  successfully  used  for
crystallization.
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Table 16: Solubility of bacterially expessed NELF variants
Protein variant Solubility
NELF-AC (+), (1)
NELF-AD (++), (1)
NELF-AC36-590 (++), (1)
NELF-A6-188C36-590 (+++), (2)
NELF-A6-188 C183-590 (+++)
NELF-ABC (++), (1)
NELF-A6-188BC36-590 (++), (3)
NELF-ABCE (+), (1), (3)
NELF-A6-188BC36-590E (++), (2), (3)
Variants are full-length proteins if not otherwise specified. (+) = low solubility, (++) = medium 
solubility, (+++) = high solubility, (1) = aggregation, (2) = slight aggregation, (3) = stable at high salt 
concentrations only (500 mM NaCl).
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The final 2Fo-Fc electron density map was contoured at 1.5 σ (grey) and the anomalous difference
Fourier electron density for the selenomethionine-labeled crystal was contoured at 4.0 σ. The final
model for NELF-C helix α4´ (Figure 8, Figure 9) is superimposed in stick representation, showing
the position of selenium atoms in selenomethionine residues (red) used for phasing.
Figure 7: Exemplary region of the electron density map
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Table 17:  X-ray diffraction and refinement statistics
Native SeMet
Data collection a
Space group I213 I213
Cell dimensions
    a=b=c (Å) 185.07 184.45
Wavelength (Å) 1.00000 0.97910
Resolution (Å) 12.3-2.75 (2.82-2.75) b 14.54-3.25 (3.33-3.25)
Rsym (%) 9 (271) 9 (130)
I / σI 32.2 (1.9) 24.0 (2.2)
Completeness (%) 100 (100) 100 (100)
Redundancy 39.8 (40.7) 20.6 (15.8)
CC (1/2) c (%) 100 (73.9) 100 (78.4)
Figure of merit for SeMet sites 0.323
Refinement
Resolution (Å) 2.75
No. reflections observed 1,093,935 657,156
No. Reflections unique 27,492 31,923
Rwork / Rfree (%) 23.7 / 25.6
No. atoms
    Protein 4434
    Ligand/ion 2
   Water 13
B-factors (Å2)
    Protein 110.8 (NELF-A)
108.4 (NELF-C)
    Ligand/ion 103.5
    Water 77.4
R.m.s deviations
    Bond lengths (Å)  0.003
    Bond angles (°)  0.662
a Diffraction data were collected at beamline X06DA of the Swiss Light Source, Switzerland
and processed with XDS (Kabsch, 2010).
b Values in parentheses are for the highest-resolution shells
c CC1/2 = percentage of correlation between intensities from random half-datasets (Karplus
and Diederichs, 2012).
41
 III Results and discussion
 1.2 Unusual structure of the human NELF-AC subcomplex
The structure of NELF-AC reveals a novel fold and an extended interface between the two
NELF subunits  (Figure 8,  Figure 9,  Figure 10B and C).  NELF-C adopts a horseshoe-
shaped structure (Figure 9). NELF-C consists of 22 α-helices (α1´-α22´) and a small two-
stranded β-sheet  (β1´-β2´,  residues 367-379) that  protrudes from the surface.  The C-
terminal half of NELF-C (helices α14´-α19´) forms three HEAT repeats (H1-H3). The HEAT
repeat region shows structural similarity (Holm and Rosenstrom, 2010) to the C-terminal
repeat  domain  (CTD)-interacting  domain  (CID)  (Meinhart  and  Cramer,  2004) and  the
polyadenylation factor symplekin (Xiang et al., 2010). Despite the presence of a CID-like
fold,  NELF-AC  did  not  show  significant  binding  to  CTD  diheptad  peptides  carrying
phosphorylations at CTD residues serine-2 or serine-2 and serine-5 (not shown). Subunit
NELF-A forms a highly conserved helical ‘N-terminal domain’ (helices α1-α5, residues 6-
110) that resembles (Holm and Rosenstrom, 2010) the fold of the HIV integrase-binding
domain in human PC4 and SFRS1-interacting protein (Figure 10A)  (Cherepanov et al.,
2005).  This  domain  is  followed  by  an  ‘extended  region’  in  NELF-A that  forms  four
additional  helices  (helices  α6-α9,  residues  111-182) arrayed  around  the  NELF-C
horseshoe (Figure 8, Figure 9). 
Both NELF-A regions interact extensively with NELF-C through hydrophobic and polar
contacts. Two invariant tryptophan side chains (W24 and W89) on the NELF-A N-terminal
domain insert into largely conserved hydrophobic pockets of NELF-C (Figure 8,  Figure
10B). The extended region of NELF-A is essential for NELF-C interaction  (Narita et al.,
2003) and contacts the N- and C-terminal regions of NELF-C with its helices α6 and α9,
respectively. NELF-A helices α7 and α8 are buried in the central surface of the NELF-C
horseshoe (Figure 10C). Overall, the heterodimer interface buries a large surface area
(3,690 Å2), explaining the high stability of the complex in 2 M sodium chloride (not shown).
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Alignment  of  NELF-A and NELF-C regions present  in  the structure  from Homo sapiens (H.s.),
Drosophila  melanogaster (D.m.)  and  Dictyostelium discoideum (D.d.).  Invariant  and  conserved
residues are highlighted in green and yellow, respectively. Barrels above the alignment represent α-
helices, arrows β-sheets. HEAT-repeats H1-H3 are marked with black lines above the alignment.
Residues residing in the heterodimeric interface and hydrophobic core residues are marked by
black  and  red  squares,  respectively.  Red  triangles  label  residues  involved  in  nucleic  acid
interaction,  blue  and  orange  dots  mark  previously  known phosphorylation  sites  located  at  the
protein  surface  and residues identified  to  be  phosphorylated by P-TEFb,  respectively.  The “N-
terminal  domain”  and  “extended  region”  of  NELF-A are  indicated.  Sequence  alignments  were
carried  out  with  ClustalW2  (Larkin et  al.,  2007) followed by manual  editing  and rendered with
JALVIEW (Waterhouse et al., 2009).
Figure 8: Conservation of human NELF-A and NELF-C
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Ribbon model of  NELF-AC with NELF-A in red and NELF-C in cyan. N- and C-termini,  mobile
regions, and truncated regions are indicated by dashed lines. The two views are related by a 180°
rotation around the vertical axis.
Figure 9: Crystal structure of human NELF-AC complex.
Figure 10: Details of NELF-AC structure and subunit interaction
(A)  NELF-A N-terminal  domain enlarged and rotated 60° around the horizontal  axis  relative to
“bottom view” (Figure 9).
(B) Detailed view of  invariant NELF-A residues W24 and W89 and surrounding residues (stick
model) interacting with the NELF-C surface. NELF-C surface conservation colored according to
Figure 8. The view is rotated by 90° around the vertical axis relative to “bottom view” (Figure 9).
(C) Detailed view of NELF-A helices α7 and α8 (stick model, residues 138–154) surrounded by
NELF-C. NELF-C surface conservation is colored according to  Figure 8. The view is rotated 60°
around the horizontal axis relative to “bottom view” (Figure 9).
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 1.3 The NELF-AC core is highly conserved
The  crystallized  regions  of  human  NELF-AC  share  considerable  homology  among
metazoans,  particularly  at  residues  forming  the  hydrophobic  cores  and  the  interface
between NELF-A and NELF-C (Figure 8).  The extent  of  conservation is evident  when
human and Drosophila melanogaster are compared, which share 55 % identity for NELF-
A and 50 % identity for NELF-C. Most regions outside of the crystallized core appear to
have diverged in metazoans, suggesting a conserved role for the central NELF-AC core
(Figure 11,  Figure 12).  Thus, the human NELF-AC structure is an excellent  model for
NELF-AC complexes in other multicellular species. 
Surprisingly,  a  part  of  the NELF-AC complex also exists  in  the single cell  slime mold
Dictyostelium discoideum. The hypothetical  Dictyostelium  proteins  DDB_G0286295 and
DDB_G0268678 share sequence similarity with NELF-A and the crystallized C-terminal
region of NELF-C (Figure 8). The conservation of many residues in the hydrophobic core
and heterodimer interface indicates that the NELF-AC subcomplex exists in this single cell
organism. A putative Dictyostelium homolog is also found for a region of human NELF-B
comprising residues 1-410  (DDB_G0284195)  (Chang et al., 2012), but not for NELF-E,
suggesting  that  Dictyostelium NELF may be composed of  a  three-subunit  NELF-ABC
complex that contains the conserved NELF-AC core.
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The alignment  compares  full-length NELF-A from Homo sapiens (H.s.),  Mus musculus  (M.m.),
Danio rerio (D.r.), Drosophila melanogaster (D.m.) and Dictyostelium discoideum (D.d.). Residues
are  colored  according  to  percent  conservation  with  brighter  colors  representing  higher
conservation. Barrels above the alignment represent α-helices, arrows β-sheets and are colored
according  to  Figure  8.  N-  and  C-terminal  borders  of  solved  crystal  structure  are  indicated.
Sequence alignment was done with ClustalW2 (Larkin et al., 2007) followed by manual editing and
rendered with JALVIEW (Waterhouse et al., 2009).
Figure 11: Multiple sequence alignment of full-length NELF-A demonstrating the comparatively 
high conservation of the crystallized region
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 1.4 NELF-AC binds single-stranded nucleic acids
Analysis of the NELF-AC surface showed that one face of the NELF-AC complex contains
four positively charged patches (Figure 13, bottom view).  Patch 1 consists of  NELF-A
residues R65 and R66 and NELF-C residues R291 and K315. Patch 2 encompasses
NELF-C residues K372, K373, and K374, and patch 3 contains NELF-C residues K384
and K388. Patch 4 is composed of NELF-A residues K146, K161, K168, and R175, and
NELF-C residues R419 and R506. These patches are well conserved among metazoa,
and are partially conserved in  Dictyostelium  (Figure 8). In addition to the four positive
47
Figure 12: Multiple sequence alignment of full-length NELF-C demonstrating the low conservation
of the N-terminal region
The alignment  compares full-length  NELF-C from Homo sapiens (H.s.),  Mus musculus  (M.m.),
Danio rerio (D.r.), Drosophila melanogaster (D.m.) and Dictyostelium discoideum (D.d.). Residues
are  colored  according  to  percent  conservation  with  brighter  colors  representing  higher
conservation. Barrels above the alignment represent α-helices, arrows β-sheets and are colored
according  to  Figure  8.  N-  and  C-terminal  borders  of  solved  crystal  structure  are  indicated.
Sequence alignment was done with ClustalW2 (Larkin et al., 2007) followed by manual editing and
rendered with JALVIEW (Waterhouse et al., 2009).
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patches, the NELF-AC surface contains a polar conserved surface (patch 5) that is formed
by NELF-A residues K166, R167, K170, L174, E177, K181, and S182, and residues E491,
K494, D498, D526, S528, R531, Y532, T535 and E536 that protrude from NELF-C helices
α18´ and α20´ (Figure 13, side view).
The  positively  charged  patches  of  NELF-AC  suggested  that  the  subcomplex  may
associate with nucleic  acid.  To investigate this  idea,  we used fluorescence anisotropy
titration assays (Figure 14,  II 2.5). We tested NELF-AC binding to fluorescently labeled,
synthetic 25-nt single-stranded (ss) DNA and ssRNA random sequence (Table 7). Indeed,
we detected binding of NELF-AC to both ssDNA and ssRNA. Regression analysis of the
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Figure 13: Surface properties of NELF-AC
Three views of the solvent-accessible surface related by 90° rotations around a vertical axis are
shown.
(A)  Surface conservation.  Residues that  are invariant  from human to  Drosophila are in  green,
conserved residues in yellow (Figure 8). Surface areas involved in nucleic acid binding (patches 1–
4) (III 1.4) are highlighted. Colors of labels according to color code of protein features belong to
(Figure 9). A conserved polar surface area (patch 5) is formed by the C-terminal region of NELF-A
and NELF-C helices α18´ and α20´.
(B)  Electrostatic  surface  potential  generated  with  ABPS.  Blue,  red,  and  white  areas  indicate
positive, negative and neutral charge, respectively. Surface areas involved in nucleic acid binding
(patches 1–4), exposed phosphorylation sites mapped  in vivo (T157, T285 and Y289) and sites
phosphorylated  by  P-TEFb  in  vitro (T173  and  T318)  are  highlighted  (III  1.5).  Colors  of  labels
according to color code of protein features belong to (Figure 9). Phosphorylation sites mapped in
vivo and in vitro are framed by blue and orange boxes, respectively (Figure 8).
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binding curves revealed that Kd values in the micromolar range (Figure 14A). In contrast,
NELF-AC did not associate with nucleic acid duplexes composed of DNA or DNA-RNA
hybrids (not shown).
To  investigate  whether  the  positively  charged  patches  were  involved  in  nucleic  acid
binding,  we generated NELF-AC variants in  which lysine and arginine residues in the
patches  were  substituted  with  methionine  and  glutamine,  respectively.  Indeed,  single-
stranded nucleic acid binding was strongly impaired in variants with mutations in three or
four of the positively charged patches (Figure 14B, C). We also tested whether single-
stranded nucleic acids corresponding to known Pol II in vivo pause sites could associate
with NELF-AC (Figure 14E). A ssRNA oligonucleotide with a sequence corresponding to a
promoter-proximal transcript from the  junB gene bound NELF-AC with a Kd of ~8.0±0.9
µM, whereas ssDNA corresponding to the non-template strand in this region bound more
weakly (Aida et al., 2006) (Figure 14D). Furthermore, ssRNA and ssDNA derived from the
c-fos  promoter-proximal  region  sequences  (Fivaz  et  al.,  2000) also  bound  NELF-AC,
albeit  with a preference for DNA (Figure 14D). Taken together, NELF-AC binds single-
stranded nucleic acids via positively charged patches, and both the strength of binding
and the preference for RNA or DNA are sequence-dependent.
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Figure 14: NELF-AC binds single-stranded nucleic acids
(A) Binding of wild type (WT) NELF-AC to 10 nM fluorescently labeled ssRNA or ssDNA with 60 %
GC content as monitored by the change in relative fluorescence anisotropy. Error bars reflect the
standard deviation from three experimental replicates.
(B, C) Binding of WT NELF-AC and variants containing mutations in surface patches (Figure 13) to
the same ssRNA (B) or ssDNA (C) used in panel A. Numbers indicate mutated patches present in
NELF-AC variants.
(D) Binding of WT NELF-AC to 10 nM of fluorescently labeled ssRNA and ssDNA derived from
natural sequences of promoter-proximal regions of paused genes junB and c-fos (II 2.5, Table 7) as
monitored by the change in relative fluorescence anisotropy.
(E) Schematic of the presence of single-stranded nucleic acids (ssRNA, ssDNA) in the promoter-
proximally paused Pol II elongation complex.
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 1.5 NELF-AC phosphorylation counteracts nucleic acid binding
The above results suggested that NELF acts at least partially during Pol II pausing by
binding  single-stranded nucleic  acids  in  the promoter-proximal  transcription  elongation
complex. Because it is known that release of paused Pol II involves NELF phosphorylation
(Chiba et al., 2010; Fujinaga et al., 2004), we hypothesized that NELF phosphorylation
counteracts nucleic acid binding by NELF-AC. In support of this, known phosphorylation
sites mapped to the nucleic acid-binding face of NELF-AC. The human NELF-A residue
T157  (Q9H3P2)  and  NELF-C  residues  T285,  Y289,  and  S301  (Q8IXH7)  can  be
phosphorylated  in  vivo (www.phosphosite.org)  and T157,  T285 and Y289 are  located
close to the nucleic acid-binding patches 1 and 4 in our structure. We therefore generated
protein  variants  with  the  phosphomimetic  mutations  T157D,  T285D  and  Y289E,  and
tested their affinity for ssRNA and ssDNA. Double mutants exhibited poor solubility. All
three variants significantly impaired binding to ssRNA and ssDNA (Figure 15), arguing that
phosphorylation of NELF-AC counteracts nucleic acid binding, and providing a possible
explanation for how paused Pol II may be released upon NELF phosphorylation.
To test whether P-TEFb can phosphorylate NELF-AC in vitro, and to investigate whether
phosphorylation may impair nucleic acid binding of NELF-AC, we prepared recombinant
P-TEFb by co-expressing  its subunits CDK9 and cyclin-T1 in insect  cells (II  2.4).  We
incubated NELF-AC with purified P-TEFb and ATP, and subjected the two NELF subunits
to  phosphopeptide  analysis  by  mass  spectrometry  (Figure  16,  Figure  17,  II  2.4).  We
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Figure 15:  In  vivo phosphorylation  of  NELF-AC counteracts  binding  of  single-stranded nucleic
acids
(A,  B)  Binding  of  WT NELF-AC  and  variants  carrying  phosphomimetic  mutations  that  mimic
phosphorylations previously identified in vivo to 10 nM of fluorescently labeled ssRNA (A) or ssDNA
(B) with 60 % GC content as monitored by changes in relative fluorescence anisotropy (same as
Figure 14A-D). Error bars reflect the standard deviation from three experimental replicates.
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indeed detected two P-TEFb dependent phosphosites corresponding to NELF-A residue
T173 (patch 4) and NELF-C residue T318 (patch 1). To ensure complete phosphorylation
and to avoid complications caused by inherent P-TEFb nucleic acid binding activity, we
cloned and purified NELF-AC variants with phosphomimetic mutations of NELF-A T173D
and NELF-C T318D. Binding experiments showed strongly decreased affinity for ssRNA
and ssDNA compared to wild type NELF-AC (Figure 18). Thus nucleic acid binding by
NELF-AC can  be  impaired  by  P-TEFb-dependent  phosphorylation  of  its  nucleic  acid-
binding face. 
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Production ion spectrum of phosphorylated peptide SATLRAELLQK (position 171 – 181) in NELF-
A. The b- and y-type fragmention ions are depicted within the spectrum and in the corresponding
peptide sequence. b-type- and/or y-fragment ions marked with an asterisk (*) are those that reveal
a loss of H3PO4 (98 Da) in the spectrum and thus contain the phosphorylated amino acid. The b3-
ion (Ser-Ala-Thr) but not the b2-ion (Ser-Ala) shows unambigiously a loss of H3PO4 so that Thr-173
is  the  phosphorylated  amino  acid.  Scan  number  is  the  according  to  Excalibur  software
(ThermoFisherScientific) and score according to MaxQuant software (Cox and Mann, 2008).
Figure 16: Identification of pT-173 in NELF-C by LC-MSMS
 III Results and discussion
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Production ion spectrum of phosphorylated peptide MFTSMDPPPVELIR (position 316 – 329) in
NELF-C.  The  b-  and  y-type  fragment  ions  are  depicted  within  the  spectrum  and  in  the
corresponding peptide sequence. b-type- and/or y-fragment ions marked with an asterisk (*) are
those that reveal a loss of H3PO4 (98 Da) in the spectrum, and thus contain the phosphorylated
amino acid. The b3-ion (Metox-Phe-Thr) shows unambiguously a loss of H3PO4 so that Thr-318 is
the  phosphorylated  amino  acid.  Scan  number  is  the  according  to  Excalibur  software
(ThermoFisherScientific) and score according to MaxQuant software (Cox and Mann, 2008).
(A,  B)  Binding  of  WT NELF-AC  and  variants  carrying  phosphomimetic  mutations  that  mimic
phosphorylations made by P-TEFb in vitro to 10 nM of fluorescently labeled ssRNA (A) or ssDNA
(B) with 60 % GC content and monitored binding by changes in relative fluorescence anisotropy
(same  as  Figure  14A-D).  Error  bars  reflect  the  standard  deviation  from  three  experimental
replicates.
Figure 18: Phosphorylation of NELF-AC by P-TEFb counteracts binding of single-stranded nucleic
acids
Figure 17: Identification of pT-318 in NELF-AC by LC-MSMS
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 1.6 Complete NELF has an accessible nucleic acid-binding face
To investigate whether the nucleic acid-binding face on NELF-AC is accessible in the four-
subunit  NELF complex,  we prepared the entire NELF complex in recombinant form (II
2.2.2). We co-expressed full-length NELF-A, NELF-C, and NELF-B carrying a solubility-
enhancing maltose-binding protein (MBP) tag in E. coli. The resulting NELF-ABC complex
was  partially  purified,  and  supplemented  with  independently  expressed  and  purified
NELF-E.  Because  the  resulting  NELF  complex  was  prone  to  aggregation,  we  also
prepared a truncated version that lacked the C-terminal region of NELF-A (residues 189-
528) and the non-conserved N-terminal tail of NELF-C (residues 1-35) (Figure 11, Figure
12,  Figure 19A,  II  2.2.2).  Similarly,  we prepared a three-subunit  truncated NELF-ABC
complex lacking the NELF-E subunit.
We crosslinked  purified  truncated three-  and four-subunit  NELF complexes  DSS and
detected lysine-lysine crosslinks by mass spectrometry as described (Herzog et al., 2012).
For the four-subunit NELF, we obtained a total of 158 unique high-confidence lysine-lysine
crosslinks,  including 70 inter-subunit  and 88 intra-subunit  crosslinks (Figure 20A).  Our
NELF-AC  crystal  structure  explained  11  inter-  and  intra-subunit  crosslinks,  with  Cα
distances below the maximum allowed distance of 30 Å (Figure 19B). This provided a
positive  control  and  argued  that  the  structure  of  NELF-AC  is  preserved  within  the
complete NELF complex. 
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(A) SDS-PAGE of pure truncated four-subunit NELF used for crosslinking analysis.
(B)  Crosslinking  of  truncated  four-subunit  NELF  complex.  Cα-atom  distances  of  lysine-lysine
crosslinks located within the known NELF-AC structure.
Figure 19: Controls of complete NELF crosslinking
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The lysine residues in the nucleic acid-binding patches were devoid of crosslinks. Patches
3 and 4 formed monolinks with the crosslinking reagent, indicating they are accessible to
solvent  (Figure  22).  Independent  crosslinking  analysis  of  the  3-subunit  NELF-ABC
complex confirmed and complemented these results (Figure 20B).  Taken together,  the
nucleic acid-binding face of NELF-AC remains accessible for nucleic acid binding in the
complete NELF complex. 
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Figure 20: Interactions detected by crosslinking
Inter-protein and intra-protein crosslinks are colored in black and in the colors of the corresponding
NELF subunits, respectively.  The crosslinking interaction map has been created using the xiNET
program (Combe et al., 2015). NELF-A, NELF-B, NELF-C and NELF-E are colored as in Figure 22.
(A) Crosslinking interaction map of a truncated 4-subunit NELF complex as determined by lysine
crosslinking followed by mass spectrometric identification of the crosslinked sites. A red loop at
NELF-B K278 indicates a self-crosslink.
(B) Crosslinking interaction map of a truncated three-subunit NELF-ABC as determined by lysine
crosslinking followed by mass spectrometric identification of the crosslinked sites.  A red loop at
NELF-B K278 indicates a self-crosslink.
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 1.7 Location of NELF-B and NELF-E
The crosslinking analysis also revealed the topology of the complete NELF. To position
NELF-B with respect to the NELF-AC structure, we first prepared a model of NELF-B. The
program I-TASSER (Yang et al., 2015) predicted that NELF-B forms a HEAT repeat fold
(Figure 22) (C-score = -2.31, best template structure is 1B3U – human PP2A). The model
is strongly supported by 54 intra-crosslinks, which suggest a strong curvature of the HEAT
repeat  fold  (Figure  20A),  as  observed  for  a  HEAT repeat  protein  folding  around  an
interaction partner (Cingolani et al., 1999).
Three distinct regions of NELF-B crosslinked to NELF-AC; the N-terminal region (residues
K72, K85 and K92), the central region (K278 and K292), and the C-terminal region (K497)
(Figure 20A, Figure 22). These three regions of NELF-B crosslink to the side opposite of
the NELF-AC nucleic acid-binding face, indicating that NELF-B and nucleic acids bind to
opposite  faces  of  NELF-AC.  The central  region  of  NELF-B  also  crosslinks  to  the  N-
terminal region of NELF-C that is not present in our crystal structure (K125). In vitro, the
N-terminal  region  of  NELF-C  bound  NELF-B  (Figure  21),  suggesting  that  NELF-B
embraces the N-terminal region of NELF-C. Crosslinks detected with the truncated four-
subunit NELF complex were corroborated by independent XL-MS experiments performed
with the three-subunit NELF-ABC complex (Figure 20B).
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Pull-down assays demonstrating that the NELF-C N-terminal region (residues 36-190) is sufficient
for  interaction  with  NELF-B.  MBP-NELF-B  was  bound  to  amylose  resin  and  incubated  with
different  NELF-AC constructs.  Only  NELF-A6-188C36-590 and NELF-C36-190 could  bind  to  NELF-B.
Asterisks mark NELF-A and NELF-C constructs added to NELF-B as described above the lanes. i
= input, e = eluate.
Figure 21: Interaction between NELF-AC and NELF-B
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Finally,  the crosslinking indicated that NELF-E is located at the periphery of NELF-ABC.
NELF-E crosslinked to NELF-B, except for one residue (K130) within a mobile region that
crosslinked to multiple distant sites on NELF-C (Figure 20). The extensive crosslinking
between NELF-E and NELF-B is consistent with biochemical interaction data (Narita et al.,
2003). A predicted N-terminal helix of NELF-E (residues 7-36) formed a crosslink to NELF-
B residue K364 (Figure 22), placing this helix near the central region in NELF-B. The RRM
domain of NELF-E  (Rao et al., 2006) (residues 257-335, PDB-code 2JX2) crosslinks to
numerous locations on NELF-B with its residues K260 and K332 on one side of the RRM
(Figure 20, Figure 22). This crosslinking pattern indicates that the RRM domain remains
mobile within NELF. Residue K326 of NELF-E is located in the RNA-binding β-sheet and
was monolinked, arguing that the RNA-binding face of NELF-E is accessible within NELF.
Taken together, our analysis revealed the topology of complete NELF and showed that
both nucleic acid-binding sites of NELF are accessible.
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Figure 22: Molecular architecture of complete NELF
Structural overview of observed crosslinks between NELF-A6-188 (red), NELF-C183-590 (cyan), NELF-B
(orange), and NELF-E (magenta). NELF-B was modeled with I-TASSER (Yang et al., 2015). Two
views related  by a  180º rotation  around a vertical  axis  are shown.  The NELF-E RRM-domain
structure was previously solved  (Rao et al., 2006) (2JX2). A predicted (Buchan et al., 2013) N-
terminal helix (7-36) and a predicted flexible region (37-261) of NELF-E are indicated. Lysines on
NELF-AC surface  forming  crosslinks  to  NELF-B  are  colored  blue  and labeled  as  in  Figure  9.
Residues of NELF-B that form crosslinks with both NELF-AC and NELF-E are blue, residues solely
forming crosslinks between NELF-B and NELF-E are green. NELF-AC patches (1-4) responsible
for nucleic acid interaction are circled and the conserved patch 5 is indicated (Figure 13, III 1.4).
NELF-AC lysine residues forming monolinks with DSS are in yellow.
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 1.8 Discussion
Understanding the mechanisms of promoter-proximal pausing and release is essential for
understanding  gene  regulation  and  ultimately  requires  structural  information  of  Pol  II
elongation complexes bound by DSIF, NELF, and P-TEFb. To this end, structures of the
involved multi-protein components are required. Structural information is already available
for Pol II elongation complexes (Martinez-Rucobo and Cramer, 2013), DSIF (Klein et al.,
2011; Martinez-Rucobo et al., 2011), and P-TEFb (Baumli et al., 2012; Baumli et al., 2008;
Schulze-Gahmen et al., 2014; Schulze-Gahmen et al., 2013; Tahirov et al., 2010), but is
lacking for NELF, except for the RRM domain of NELF-E  (Rao et al., 2006; Rao et al.,
2008). To close this gap, we report here the overall architecture of NELF and the crystal
structure of  its conserved core subcomplex NELF-AC.  In addition,  we report  a single-
stranded  nucleic  acid-binding  function  of  NELF-AC  that  is  repressed  by  P-TEFb-
dependent phosphorylation of the NELF-AC surface. Our results are generally relevant for
understanding NELF function and the mechanisms of Pol II pausing because the NELF-
AC structure and functionally important residues are conserved.
Based on our data and available literature (Chiba et al., 2010; Yamaguchi et al., 1999a)
we propose that Pol II pausing involves binding of NELF-AC to nascent RNA, and that Pol
II  release  involves  phosphorylation  of  the  RNA-binding  face  of  NELF-AC by  P-TEFb,
thereby impairing RNA binding. We also suggest a topological model for NELF interaction
with the promoter-proximally paused Pol II-DSIF transcription elongation complex (Figure
23).  In this model,  the positively charged face of  NELF-AC interacts  with exiting RNA
because in a Pol II-DSIF elongation complex ssRNA is accessible, whereas non-template
ssDNA is most likely not (Martinez-Rucobo et al., 2011). The NELF-A region immediately
following the region in our structure (residues 189-248) is flexible (proteolysis data not
shown) and may interact with the Pol II clamp  (Yamaguchi et al., 2007).  The adjacent,
highly conserved surface patch 5 on NELF-AC (Figure 13, side view) may contribute to
Pol II binding or may bind DSIF or another factor, such as P-TEFb. NELF-B and NELF-E
are likely  oriented away from the Pol  II  surface,  but  NELF-E is flexible and can bind
nascent RNA when it is approximately 70 nucleotides long  (Missra and Gilmour, 2010;
Pagano et al., 2014; Rao et al., 2008). The comparatively weak affinity of NELF-AC for
nucleic  acids would not  contradict  our  model  since upon binding  to the  Pol  II  clamp,
NELF-AC is positioned close to nascent RNA effecting an increases binding efficiency.
Further,  for  reversible  protein-nucleic  acid interactions the affinity  of  individual  binding
sites would be expected to be rather weak so nucleic acids can be released easily.
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It is known that the extent of Pol II pausing strongly differs between different genes (Muse
et al., 2007). Such gene specificity may be explained by differences in promoter-proximal
DNA regions. How can DNA sequence influence pausing? First, certain sequences may
lead to DNA-RNA hybrids that favor Pol II pausing by slowing down the elongation rate,
similar to DNA sequences that influence pausing of bacterial RNA polymerase (Greive and
von Hippel, 2005; Larson et al., 2014; Vvedenskaya et al., 2014). Second, nascent RNA
may bind  to  NELF with  different  affinities,  directly  influencing  the  efficiency  of  NELF
recruitment to pausing sites. Indeed we observed that nucleic acid binding of NELF-AC is
strongly sequence-dependent. It is also known that DNA regions differ in their GC content
(Ginno et al., 2012) and in Drosophila there is a known sequence motif that is associated
with pausing (Hendrix et al., 2008). Third, nucleosome stabilities vary with DNA sequence
and nucleosomes are known to influence Pol II elongation (Gilchrist et al., 2010; Gilchrist
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Figure 23:  Topology  of  a  promoter-proximally  paused  Pol  II  transcription  elongation  complex
containing DSIF and NELF
NELF (Figure 22) was positioned next to the previously published Pol II-DSIF elongation complex
model  (Martinez-Rucobo et al., 2011). We used a single scale to allow for a comparison of the
relative sizes of the complexes. The view of NELF-AC is rotated 90° relative to the ‘bottom view’ in
Figure 9 and Figure 13 around the vertical axis. The positively charged, nucleic acid-binding face of
NELF-AC was oriented towards RNA exiting Pol II. Note the Pol II-binding region of NELF-A that
may contact the Pol II clamp helices (violet) is not present in the NELF-AC structure. The presumed
interaction between the NELF-A Pol II-binding region and the Pol II clamp domain positions the
NELF complex close to the RNA exit tunnel of Pol II.
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et al., 2008; Mayer et al., 2015).
Our results are essential for deciphering the molecular basis of Pol II pausing and release
and its sequence dependency and thus gene specificity. We note that nucleic acid binding
alone may explain recruitment of NELF to certain genes and its association with promoter-
proximal regions,  but  is  insufficient  to explain Pol  II  pausing,  which would additionally
require  a  change  in  the  elongation  behavior  of  the  polymerase.  This  may  involve  a
conformational change in the enzyme that may be triggered or stabilized by NELF binding
to the Pol II surface. Analysis of this intricate mechanism awaits the formation of functional
complexes comprising Pol II, DSIF, and NELF, and their structural analysis.
 2 Further analysis of the NELF subcomplex NELF-AC
Results described in this chapter have been obtained during this thesis. They support and
broaden the results described in chapter III 1 but were not published.
 2.1 Crystallization experiments with NELF-A6-188C36-590
A first  phase  of  limited  proteolysis  using  chymotrypsin  and  subsequent  truncation  of
mobile  and  unconserved  regions  resulted  in  a  highly  soluble  and  compact  construct
consisting of NELF-A (6-188) and NELF-C (36-590) (‘NELF-A6-188C36-590’) (Figure 6B, C).
Validity of this result was supported by bioinformatic analysis predicting NELF-C to consist
of a single and entirely alpha helically structured TH1 domain comprising the conserved
region 36-590 (Figure 3A, Figure 12) (Buchan et al., 2013; Marchler-Bauer et al., 2011).
Pure NELF-A6-188C36-590 formed trimers as determined by size exclusion chromatography
(Figure 24A) and dynamic light scattering (~250 kDa extimated size, monomer: 85.8 kDa)
with  an  RSD of  24.5  %.  Thin  needle  shaped  crystals  were  obtained  after  extensive
screening  (II  2.3.1,  Figure  25A).  However,  the  small  size  and fragility  of  the  crystals
prevented us from collecting diffraction  data.  To improve crystal  quality  we varied  the
termini  of  the construct  NELF-A6-188C36-590 with the objective to remove flexible terminal
sequences not identified before or add terminal amino acids important for crystal contacts
(Table  4 ‘DP33-DP47’)  (Derewenda,  2004).  The four  termini  of  NELF-A6-188C36-590 were
varied individually with the remaining three termini invariant resulting in NELF-A constructs
with N-termini beginning at S9, T20, G29 or A36 and C-termini ending at S182, S193 or
R202. NELF-C N- and C-termini were defined at Q30, S52, D55 or I57 and N559, T568,
D573 or N585, respectively. Yet none of these constructs could improve crystal quality.
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Our second approach to enhance the quality of NELF-A6-188C36-590  crystals was based on
surface  entropy  reduction  (Cooper  et  al.,  2007;  Derewenda,  2004;  Derewenda  and
Vekilov,  2006).  Clusters  of  flexible  and polar  side  chains,  in  particular  glutamate  and
lysine, comprise a high entropy and consecutively account for protein-protein repulsion
preventing crystallization. Mutation to alanine thus can increase chances of  successful
crystallization.  Based  on  results  of  the  “surface  entropy  reduction  prediction  server”
(Goldschmidt et al., 2007) four high-entropy clusters were modified: NELF-A E111, E112,
Q113; NELF-C E138,  E139,  E141;  NELF-C Q270, E271,  K272; NELF-C K371,  K372,
K374. Clusters were mutated to alanine individually and in combinations (Table 4, ‘DP48 -
DP53’).  We found  that  all  mutations  did  not  affect  protein  solubility.  However,  crystal
quality could not be increased.
In a second phase of limited proteolysis we found that subtilisin cleaves the N-terminal
region of NELF-C (36-189) resulting in the new construct NELF-A6-188C183-590 (‘NELF-AC’)
(Figure 6C and D,  III  1.1). Pure NELF-A6-188C183-590 was homogeneous and showed no
signs of aggregation as demonstrated by size exclusion chromatography (Figure 24B).
Using DLS the particle size was calculated to 60 kDa (65.9 kDa in theory) with an RSD of
19.1 %.
In combination with results from interaction assays (Figure 21) we concluded that NELF-C
consists of at least two compact and independently folding regions 36-189 and 190-590.
The NELF-C N-terminal region accounts for aggregation of NELF-A6-188C36-590, possibly due
to the lack of its binding partner NELF-B. Thus crystallization of the NELF-C N-terminal
region presumably requires previous complex formation with NELF-B.
Initial  crystallization  screens  with  NELF-A6-188C183-590 (Table  15)  identified  aplenty  of
predominantly  polyethylene  glycole  (PEG)  containing  crystallization  conditions  (not
shown) providing a basis for optimization and consecutive structure solution as described
in III 1.1 (Figure 25B, C).
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Figure 24: Size-exclusion analysis of truncated NELF-AC subcomplexes.
Size exclusion chromatography of trimeric NELF-A6-188C36-590 (A) and monomeric NELF-A6-188C183-590
(B). Truncation of the NELF-C N-terminal region (36-182) results in a substantial shift towards a
higher  retention  volume (13.8 and 16.0 ml,  respectively)  and hence lower  apparent  molecular
weight (250 and 65 kDa, respectively). For both size-exclusion chromatographies a Superose 6
10/300 column equilibrated in size exclusion buffer A was used. The blue and red curves indicate
absorption in milli absorption units (mAU) at 280 nm and 256 nm, respectively.
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 2.2 In depth analysis of NELF-AC interactions with nucleic acids
Additional fluorescence anisotropy experiments measuring the interaction between NELF-
A6-188C183-590 wildtype or mutant protein and nucleic acids enabled us to further explicate
and differentiate the results obtained in chapters III 1.4 and III 1.5.
NELF-AC preferentially binds nuleic acids with high GC content
We tested ssDNA and ssRNA with 44 %, 60 % and 72 % GC content as described in III
1.4 (II 2.5, Table 7). We found a low affinity of NELF-AC for both 44 % ssDNA and ssRNA.
Binding assays using nucleic acids with higher GC content (60 % and 72 %) yielded no
clear pattern. However, by trend nucleic acids with higher GC content exhibited a higher
affinity  to  NELF-AC (Figure  26).  Affinites  of  natural  sequences  supported  this  results
(Figure 14D): In vivo c-fos ssRNA sequence (60 % GC content) showed a lower affinity to
NELF-AC compared to in vivo junB ssRNA,  junB ssDNA and c-fos ssDNA (76 %, 75 %
and 75 % GC content, respectively). Summarized, NELF-AC tends to bind to nucleic acids
with high GC content more tightly than to nucleic acids with low GC content.
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(A) Needle shaped crystals of NELF-A6-188C36-590 WT grown in 1.15 M (NH4)2SO4, 0.2 M NaCl, 0.1 M
Na-HEPES pH 7.4. Despite extensive protein modification quality improvement was not possible.
(B) Crystallization screen Hampton Research Index HT, condition H3 (0.2 M Sodium malonate pH
7.0  and  20  %  w/v  Polyethylene  glycol  3,350).  This  condition  was  used  as  starting  point  for
successful optimization.
(C) Optimized  NELF-A6-188C183-590 crystal that was used to solve the structure, mounted in a cryo-
loop. The size of the tetraedric shaped crystal was ~300x200 µM. The crystal was grown in 0.2 M
Sodium malonate pH 7.0 and 14.25 % w/v Polyethylene glycol 3,350 (II 2.3.2).
Figure 25: Crystallization of NELF-AC variants
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Surface patch 1 is essential for interaction with nucleic acids
We asked whether specific surface patches contribute to nucleic acid binding in particular.
Hence, in addition to the combined mutation of three or four surface patches (Figure 14B
and C, III 1.4) we generated NELF-AC variants containing individual mutations of patches
1, 2, 3 or 4 (Figure 13). We then tested their affinity for fluorescently labeled, synthetic 25-
nt  single-stranded  ssDNA and  ssRNA random sequence  with  60  % GC content  and
ssDNA random sequence with 72 % GC content (III 1.4,  Figure 27, Table  7). We found
that mutation of patch 1 strongly reduced binding to all three nucleic acids tested. Patch 1
thus appears to be crucial for binding nucleic acids. In contrast, mutating patch 2 had little
effect on the affinity for both types of nucleic acid in general. Binding assays with NELF-
AC variants  carrying  mutations in  patches 3 and 4 produced ambiguous results,  only
interaction with ssDNA but not ssRNA was affected. Taken together patch 1 is an essential
binding site for nucleic acids while patch 2 contributes to binding of nucleic acids to a
minor  extent  and rather  stabilizes  the interaction.  Contribution  of  patches  3  and 4 to
nucleic acid binding remains unclear.
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(A, B) Binding of WT NELF-AC to 10 nM of fluorescently labeled ssRNA (A) or ssDNA (B) with 44
%, 60 % or 72 % GC content as monitored by the changes in relative fluorescence anisotropy
(same  as  Figure  14A-D).  Error  bars  reflect  the  standard  deviation  from  three  experimental
replicates.
Figure 26: NELF-AC preferentially binds single stranded nucleic acids with high GC content
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Binding of WT NELF-AC and variants containing one or four mutations in surface patches to 10 nM
of fluorescently labeled ssRNA (A), ssDNA (B) with 60 % and ssDNA (C) with 72 % GC content as
monitored by the changes in relative fluorescence anisotropy (same as  Figure 14A-D). Numbers
indicate mutated patches present in NELF-AC variants (Figure 13). Error bars reflect the standard
deviation from three experimental replicates.
Figure 27: Effect of mutating individual suface patches on NELF-AC affinity for nucleic acids
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 2.3 Discussion
Detailed analysis of interaction between NELF- A6-188C183-590 and nucleic acids revealed a
differentiated  pattern.  The  observed  significance  of  patch  1  for  nucleic  acid  binding
becomes momentous in view of  its vicinity to the phosphorylation sites NELF-C T285,
Y289 and T318. Phosphorylation abrogates the nucleic acid binding capacity of a nearby
patch by neutralizing the positive charge. Indeed, phosphomimetic mutations T285D and
Y289E reduce nucleic acid affinity much stronger than NELF-A T157D, which is located
proximal  to  the  positive  patch  4  (Figure  15).  Thus  our  results  explain  the  efficient
regulation of  nucleic acid binding by phosphorylation. Further, multiple phosphorylation
sites  that  are  presumably  controlled  by  different  kinases,  provide  the  possibility  for
dynamic regulation of promoter-proximal pausing.
The observed tendency of NELF-AC to stronger bind nucleic acids with high GC content
can contribute to explaining the establishment of promoter-poximal pausing. Gene regions
circumjacent  and  downstream  of  the  TSS  exhibit  a  significantly  above-average  GC
content (Ginno et al., 2013; Ginno et al., 2012). A preference of NELF-AC for nucleic acids
with  high  GC  content  sequences  would  ensure  a  tight  grip  and  prevent  unspecific
interactions outside promoter-proximal pausing regions.
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Since NELF has been discovered in 1999  (Yamaguchi et al., 1999a) numerous studies
revealing the biochemistry (Li et al., 2013; Missra and Gilmour, 2010; Narita et al., 2003;
Wu et al., 2005) and genomic function  (Fujita and Schlegel, 2010; Gilchrist et al., 2008;
Williams et al., 2015; Zeitlinger et al., 2007) were published. The structure of the common
and widespread  (Koonin and Makarova, 2013) NELF-E RRM domain has been solved
(Rao et al., 2006; Rao et al., 2008) and two functional regions of NELF-A, the NELF-C
and the Pol-II interaction domain, have been mapped (Narita et al., 2003). The general
importance  of  NELF  for  transcriptional  regulation  has  recently  been  recognized
(Yamaguchi et al., 2013). Yet, no specific structural information on NELF was available to
date. 
In this work we could solve the high-resolution structure of a highly conserved NELF-AC
subcomplex  and  identify  a  binding  site  for  single  stranded  nucleic  acids  previously
unknown.  NELF-AC affinity  for  nucleic  acids  strongly  depends  on  sequence  and  GC
content  and  can  be  regulated  through  phosphorylation  by  P-TEFb  and  likely  other
kinases. Analysis of the holo-NELF architecture showed that both single stranded nucleic
acid  binding  faces  are  located  at  opposite  ends  of  the  NELF  complex  and  freely
accessible.  These  results  allowed  to  propose  a  model  describing  the  topology  of  a
pausing complex and the molecular basis of NELF action.
Our model now needs to be reviewed, verified and expanded. It provides a starting point
for  future  structural  and  mechanistic  studies  to  deeper  understand  the  molecular
background of  promoter-proximal  pausing.  However,  important  aspects  of  the pausing
mechanism such as the change in Pol II conformation upon NELF binds to Pol II and
resulting  consequences  for  the transcription rate cannot  be explained yet  and require
further research.
The next steps to better understand NELF are in-depth analysis of  the function of  the
NELF-AC subcomplex and the  structural  characterization  of  further  parts  of  NELF.  In
continuation of this work two major points should be addressed. First, the specificity and
biological  relevance  of  the  newly  identified  NELF-AC  nucleic  acid  binding  capacity.
Despite the relatively weak interaction (Kd ~10 µM), binding is not unspecific as proven by
the  strong  sequence  dependency.  One way  to  verify  the  significance  of  nucleic  acid
binding  in  vivo could  be  to  knock  out  NELF-A  and  -C  genes  in  cell  culture  and
subsequently  replenish  NELF-A and  -C  carrying  mutations  in  positive  patches.  The
resulting  cells  can  then  be  analyzed  globally  for  differences  in  transcription  and
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specifically  for  defects  in  promoter-proximal  pausing  at  well-known paused genes like
hsp70 or junB. Consecutively the specificity of NELF-AC for single stranded nucleic acids
regarding  type,  sequence  and  secondary  structure  needs  to  be  determined  in  vivo.
Although in vivo interaction with ssDNA is less probable than with ssRNA, as discussed
above, our results were ambiguous. PAR-CLIP to discover RNA-bound NELF (Hafner et
al.,  2010),  chromatin  immunoprecipitation  of  DNA-bound protein  and related  methods
would  clarify  this  question.  Subsequently,  the  preference  of  NELF-AC  for  specific
sequences, sequence motifs or sequence characteristics like the GC content should be
defined  more  accurately  by bioinformatic  analysis  of  in  vivo experiments  and  in  vitro
validation  of  data  using  systematic  evoluation  of  ligands  by  exponential  enrichment
(SELEX)  as  demonstrated  for  NELF-E  RRM  (Pagano  et  al.,  2014).  Once  a  tightly
interacting nucleic acid has been identified, crystallization of NELF-AC and its nucleic acid
ligand is within the realms of possibility. Structural elucidation of a NELF-AC-nucleic acid
complex would render a deeper insight into the interaction between the two molecules
possible. Since NELF-AC was crystallized in a variety of PEG-containing conditions (III
2.1) this provides a promising starting point.
Another important question emanating from this work is for the function and interaction
partners of the highly conserved NELF-AC surface area ‘patch 5’ (Figure 13). This site is
outstanding  in  the  context  of  the  generally  well  conserved  NELF  surface  and  likely
fundamental for NELF function. One approach could be comparative pull-down assays
using affinity-tagged NELF-AC subcomplexes with and without mutations in patch 5 and
NELF-depleted  nuclear  extracts  as  demonstrated  previously  (Narita  et  al.,  2003)  or
alternatively in vivo over-expression of affinity-tagged NELF-AC followed by pull-down.
Structural studies on other NELF subunits as well  are necessary to clarify how NELF
contributes  to  establish  promoter-proximal  pausing.  Crystallization  of  NELF-AC  has
revealed a novel function and its regulation as well as a highly conserved surface area
previously unknown. Similarly, high-resolution structures of other NELF regions might lead
to unexpected new discoveries.  Regarding its  stucture and function NELF-B is  poorly
analyzed.  Considering the high sequence conservation of  NELF-B (Figure 3A)  and its
central position within the NELF complex (Figure 22)  (Narita et al., 2003), resolving the
structure would be an important step. A promising approach might be co-expression of
NELF-B carrying a solubility-enhancing tag together with the NELF-C N-terminal region
(36-189)  (Figure  21)  followed  by determination  of  a  minimal  complex  using  repetitive
limited  proteolysis  and  truncation  as  applied  successfully  for  crystallizing  NELF-AC.
Results obtained during this thesis indicate a flexible linker between NELF-C N- and C-
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terminal region (36-189 and 190-590) (Figure 6). For that reason successful crystallization
of a NELF-ABC complex presumably requires genetic engeneering of this linker region.
Determining the position of the NELF-E RRM on the NELF-B surface and in the context of
complete NELF would allow to better estimate the minimal length of a nascent RNA bound
to the RRM and the significance of NELF-E in promoter-proximal pausing  (Missra and
Gilmour, 2010). The flexible linker region between the predicted NELF-E N-terminal helix
(7-36) and the RRM would allow the RRM to be dynamic within NELF if it was not fixed on
the  NELF-B  surface.  Defining  the  position  of  the  N-terminal  helix  on  NELF-B  more
precisely thus is important, too. This could be achieved by co-crystallization of NELF-B
and the NELF-E region 7-36.  
Structure and function of the partially conserved NELF-A C-terminal region (249-528) are
unknown (Figure 3A, Figure 11). This part of NELF-A has been analysed in the context of
the bachelor thesis of Denis Höfler. All results are described in this work. In brief, we found
that NELF-A C-terminal region can be separated into two stable and soluble subregions
(250-369,  349-528)  that  can  readily  be  expressed  and  purified.  However,  successful
crystallization requires further construct optimization.
The final question is how NELF action pauses elongating RNA polymerase. In order to
find the answer to this question, the interactions of NELF with other protein complexes
need to be analyzed. A first step would be to identify the NELF binding site on the Pol II
surface. The inherently unstable and likely unfolded Pol II-interaction region of NELF-A
(Narita  et  al.,  2003) (189-248)  presumably  requires  an  interaction  partner  to  adept  a
defined  conformation.  Crosslinking  of  a  Pol  II-NELF  complex  coupled  with  mass-
spectrometry could locate the position of NELF on Pol II. As mentioned above (III 1.8)
detailed structural studies with a ternary pausing complex of Pol II-DSIF-NELF including a
nucleic  acid  scaffold  are  requisite  to  obtain  an  overview  of  all  molecular  aspects  of
pausing.  Cryo-electron  microscopy  studies  of  large  complexes  combined  with
crystallographic data from subcomplexes or crosslinking were proven to be a powerful
approach to such problems  (He et al., 2013; Klein et al., 2011; Martinez-Rucobo et al.,
2015). With the crystallization of large functional complexes possibly being intricate, cryo-
electron  microscopy  studies  of  a  complete  pausing  complex  accompanied  by  x-ray
analysis  of  subcomplexes  would  be  the  method  of  choice  to  answer  the  molecular
enigmas of the pausing complex.
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l liter
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M molar (mol/liter)
mAU milli absorption units
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miRNA micro RNA
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MW molecular weight
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NCBI National Center for Biotechnology Information
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Ni-NTA nickel-nitrilotriacetic acid
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OD600 optical density at 600 nm 
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P-TEFb positive transcription elongation factor
PA polyacrylamide
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PCR polymerase chain reaction
PEG polyethylene glycol
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Pol DNA-dependent RNA polymerase
ppp promoter-proximal pausing
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Rb rubidium
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rRNA ribosomal RNA
RRM RNA recognition motif
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sec/secs second/seconds
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SELEX systematic evoluation of ligands by exponential enrichment
SLS Swiss Light Source
snRNA small nuclear RNA
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ssRNA single-stranded RNA
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Temp temperature
TFII transcription factor of pol II
TFB-I/II transformation buffer I/II
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tRNA translator RNA
TSS transcription start site
v/v volume per volume
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Abbrevations
Nucleotides
A adenine
C cytosine
G guanine
T thymine
U uracil
Amino acids
A alanine
D aspartate
His histidine
K lysine
Q glutamine
R arginine
S serine
T threonine
Y tyrosine
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